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1. Introduction
Neurodegenerative disorders and traumatic injuries to the central nervous system (CNS) can
cause severe and irreversible damage. Nowadays there are few clinical therapies to treat brain
damage, and they achieve low functional recovery; most of them are based on drug adminis‐
tration for neurodegenerative diseases with well-defined targets as Parkinson’s disease. For
traumatic injuries such as traumatic brain injury (TBI), spinal cord injury (SCI), and stroke
there is no effective treatment to restore lost functions and the clinical approaches are symp‐
tomatic and based on minimizing the damage progression or enhance local plasticity with
rehabilitation. On the whole, the limitations of current therapies underline the need to search
for novel strategies.
Brain damage has constituted up to now a theoretically unsolvable problem. This was because
three of the most important tenets in neurobiology were against the restoration of the brain
after damage: 1) there are no new neurons, 2) axons cannot grow within the CNS, and 3)
neurons cannot produce new connections between them. Although these tenets have been
questioned due to research done during the last decades, there is currently no clinical appli‐
cation useful to produce reconstruction of brain damage. This is probably due to several causes:
endogenous regeneration in the adult human brain is, although present, insufficient to recover
the lost neuronal population; also, axonal elongation is highly repressed by inhibitory factors,
and the lack of the appropriate neurotropic factors and guidance cues. Furthermore, compared
to other organs, the brain is a very complex system and it does not suffice to get a high number
of new neural cells and connections between them, but these connections between new and
old neurons must be exactly organized.
Thus, the problem of neural regeneration includes mainly three processes: the need to have
new neurons to replace the lost ones, the need to promote axonal regeneration within the CNS
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to the appropriate targets, and the need to make functionally effective connections with the
same connectivity of the lost ones.
Despite the existence of neurogenesis in the adult mammalian [1] and human [2] brain, cell
replacement cannot be accomplished because of the massive death of new cells. After injury,
there is an increased neurogenesis and migration to the damaged area. In an experimental
model of stroke, new neurons appeared at the core ischemic area [3]. However, 80% of these
neurons disappear from the core 5 weeks after stroke, probably because they die or migrate to
other areas. A probable hypothesis for this phenomenon is that the core ischemic zone is not
a proper environment for cell survival, since it lacks vascularization, stromal structure or
trophic sustain for these cells.
In humans with amyotrophic lateral sclerosis and frontotemporal dementia, an increased
proliferation of neural progenitors can be seen which is not able to restore the disease condition
[4], probably because these cells die because of the action of a toxic environment produced by
the disease.
Biomaterials could constitute a proper environment to facilitate vascularization, provide
structural scaffold and improve the milieu in order to facilitate the survival of the newly formed
cells [5].
2. Neurogenesis in the adult mammalian brain
It is currently well accepted that most of the neurons in the CNS are produced both in the
prenatal as well as in the early postnatal stage. Moreover, during the past decades, neurogen‐
esis in the adult brain of mammals has been reported, humans included. Adult neurogenesis
has been shown to occur in two main areas of the adult mammalian brain: the olfactory bulb
(OB) and the dentate gyrus (DG) of the hippocampus. While in the hippocampus stem cells
and new neurons coexist together, the new neuronal cells in the OB are generated from neural
progenitor cells in the anterior part of the subventricular zone (SVZ). The SVZ is a narrow
region of tissue within the wall of the lateral ventricle in the forebrain. The neural progenitor
cells of the SVZ migrate to the OB where they differentiate into interneurons such as granule
and periglomerular cells [6]. It is known that a different migration exists from the SVZ to corpus
callosum, where cells differentiate preferentially into oligodendrocytes wich could be a target
for treatment of neurodegenerative diseases where myelin regeneration is required [7]. There
is little evidence of the existence of alternative pathways for cell migration under normal
conditions, from neurogenic areas to other regions of the brain. However, it is known that
when damage occur such as in ictus, TBI or SCI it is possible to find migration from neurogenic
niches to the injured region [8].
2.1. Structure and organization of subventricular zone and dentate gyrus in mammals
As mentioned above, stem cells responsible of adult neurogenesis in the OB, have their origins
in the SVZ, and migrate along a restricted pathway, called the rostral migratory stream (RMS).
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The RMS in mice has a length between 5 y 6 mm. Two principal cellular types were observed
in the RMS: type A cells (migrating cells) and type B cells (astrocytes). In sagittal sections, type
B cells and their processes flanked the chains of type A cells. In frontal sections, type B cells
ensheathed the chains of migratory cells [6].
In the SVZ, have been identified at least four different cell types: type A (migrating cells), type
B (astrocytes), type C (proliferative precursors or neuroblast) and type E (ependymal cells),
these cells were defined by their immunological markers and morphology. Using proliferation
markers such as 3HT or BrdU, the most actively dividing cell in the SVZ corresponded to Type
C cells [9].
Briefly, the characteristics of the 4 types of the SVZ are: Type A cells (migrating cells), equiv‐
alent to those observed in the RMS. Their major characteristics were an elongated cell body
with one or two processes, abundant lax chromatin with two to four small nucleoli, and a scant,
dark cytoplasm containing many free ribosomes and many microtubules oriented along the
long axis of the cells. The nuclei of Type A cells were occasionally invaginated. Furthermore,
their membranes showed cell junctions intercalated with large intercellular spaces that allow
cell movement. These cells were grouped forming chains and show immunoreactivity to PSA-
NCAM, Dlx-2 and TuJ1.
Type B cells (astrocytes) formed a wide network adjacent to ependymal cells surrounding the
chains of migrating cells (Type A cell). The cytoplasm of Type B cells was light and contained
few free ribosomes. One of the most important characteristic of type B cells was the presence
of extensive intermediate filaments in their cytoplasm, and they have also irregular contours
that profusely filled the spaces between neighbouring cells. These cells had irregular nuclei
that frequently contained invaginations.
Currently type B cells are divided into two subtypes: B1 and B2. Type B1 cells make contact
with the ventricular cavity while B2 cells do not. B1 cells show one short cilium to the ven‐
tricular cavity, named primary cilium. The number of B1 cells in contact with the ventricle
increases drastically when growth factors such as Epidermal Growth Factor (EGF) or ephrins
are injected [10,11], possibly the necessary signals for activation are in the cerebrospinal fluid
where, probably, the primary cilia could play an important role. Both B1 and B2 cells are
immunoreactive against GFAP, vimentin and nestin and no molecular marker can differentiate
them. Type B2 was similar to those described in the RMS.
Type C cells (precursor cells) were larger, more spherical (less elongated), and more electron-
lucent than Type A cells but more electron-dense than Type B cells. Their nuclei contained
deep invaginations and mostly lax chromatin, although sometimes the chromatin was
clumped. Type C cells had a typical large reticulated nucleolus. Their cytoplasm contained
fewer ribosomes than Type A cells, and no bundles of intermediate filaments of Type B cells.
Groups of C cells (2-3 cells) are associated with the chains of A cells. C cells are immunoreactive
against Dlx-2, a transcription factor, although this marker is not exclusive to this type of cell.
Type E (ependymal cells) formed an epithelial monolayer separating the SVZ from the
ventricular cavity. Their main distinguishing characteristics were as follow: the lateral
processes of adjacent ependymal cells were heavily interdigitated and contained apical
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junctional complexes. The surface exposed to the ventricular cavity contained microvilli and
is ciliated. The cytoplasm was electron-lucent and contained many mitochondria and basal
bodies located in the apical cytoplasm. Their nuclei were spherical, and the chromatin was
non-clumped. These cells are immunoreactive against vimentin, S-100 and CD-24. In addition,
microglia, a few pyknotic cells, mitoses, and large neurons were observed sporadically in the
SVZ. Furthermore the presence of a blood vessel network plays an important role in the SVZ
and there are evidences that the activation of the neurogenic niches is directly related with this
network [12,13].
The DG is the other region within the brain where neurogenesis takes place in mammals
[14,15]. The function of neurogenesis in the hippocampus has been correlated with memory
and learning. The DG is composed of small neurons called granular cells that are typically
packed in a V-shaped band. Stem cells are located in the inner of this band and these are
responsible for generating new neurons, which will be placed at the cell body layer. Moreover,
astrocytes have been identified in the DG as neuronal stem cells [16]. These cells are identified
as radial cells, crossing the entire thickness of the cell layer. It is also known that before
immature cells transform into mature neurons, they are partially isolated from the environ‐
ment by astrocytes, and it is thought that probably astrocytes will allow the differentiation to
mature and functional neurons. At ultrastructural level, these stem cells are similar to the
astrocytes in the SVZ. Before the transformation to mature neurons, stem cells within the DG
go through an intermediate stage of indifferentiation, named Type D cells. These cells are
characterized by lax cromatin, a crescent number of ribosomes and mytochondrias in the
cytoplasm.
Although OB and hippocampus are the most studied and widely believed neurogenic regions,
it is thought they are not the only ones. Probably more cells exist and keep their proliferative
capacity within the brain, maybe in the surroundings of the ventricular cavities. Recently
neurospheres have been obtained from the channel spinal cord of rodents, confirming the
existence of stem cells in the channel, although the nature of the cell responsible for such
proliferation is unknown [17].
2.2. Ventricular zone in humans: Organization and structure
After demonstrating the neurogenesis exist in the human [18], the new step has been the
identification and location of the stem cells responsible for adult neurogenesis in humans. They
have been located in the walls of the lateral ventricles displaying markers of astrocytary type
cells with GFAP. These cells proliferate in vivo and in vitro and give rise to neurospheres that,
in certain conditions of culture, differentiate in neurons, astrocytes and oligodendrocytes
proving the existence of stem cells [19].
The organization of the SVZ in the human brain is very different from the one in rodents.
Basically, three layers have been identified which have been denominated: 1) ependymal cell
layer, 2) Gap layer and 3) Ribbon layer. The ependymal cells layer is formed by a monolayer
of cubic cells in contact with the ventricular light that show long radial expansions into the
neurophil, containing intermediate filaments and some mitochondria and constituting the
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second or Gap layer. In the ventricular wall, facing the light, numerous cilia and microvilli can
be seen as well as the unions between them [20].
The second layer (Gap) is formed by expansions of astrocytes from the layer ribbon and
ependymal cells, and is known as hipocellular layer because of its low quantity of cell bodies.
The astrocyte expansions contain abundant intermediate filaments and numerous desmo‐
somes between them. Another interesting fact is the existence, in this layer, of ependymal cell
aggregates. These cells make up little groups of 5 to 20 cells that have the typical organization
of the ependymal cells.
Finally, the third layer, also known as Astrocyte Ribbon, is formed by large astrocytes,
myelinated axons, oligodendrocytes and a progressive increase of synapses, as we move away
from the ventricular cavity. Astrocytes of this layer have been considered stem cells. Also, there
is an interesting fact about the astrocytes that occasionally send a long prolongation, which
makes contact with the ventricular light [20]. This fact agrees with what has been seen in the
mice SVZ, where presumably, there has been an activation of the neurogenesis by the cells in
contact with the ventricular cavity and the appearance of neuronal soma limits the following
layer [9]. The main difference with rodents is the lack of precursor or Type C cells and migrating
cells.
2.3. The human brain with neurogenic features: Other regions?
The  use  of  trophic  factors  such  as  basic  fibroblast  growth  factor  (bFGF),  brain-derived
neurotrophic factor (BDNF), platelet-derived growth factor (PDGF), epidermal growth factor
(EGF) allows us to prove the presence of “sleeping” stem cells in other regions of the brain
[21–25]  like  the third and fourth ventricles  [26–28].  But,  not  only proliferation has been
found in these walls, since there are authors that support the existence of neurogenic places
distributed in the neurophil [29,30]. Therefore, in these last years there have been studies
in which the formation of new neurons in the adult cerebral cortex of mice [29–31] and
primates [32] has been proved. These findings have originated controversy between diverse
investigation groups because the results cannot be totally duplicated, existing experimen‐
tal  variations to find the “new neurons” [33]  and,  sometimes,  it  is  even possible  that
immature cells change to stem cells due to a certain stimulus [34].
Furthermore, the neurogenic term has been questioned since some authors think that, to
consider a place as neurogenic, new neurons have to be produced or recruited in normal
conditions and without the presence of any stimulus like an injury or an external trophic factor
[33,35]. The neocortex, striatum, amygdala, substantia nigra (SN), channel spinal cord, third
and fourth ventricle are some of the areas that are being proposed as neurogenic niches in
mammalians including the human [26,28,33,36–38].
3. The injured central nervous system and the regenerative process
Regeneration in the adult nervous system is limited compared with other tissues. This
limitation is due to the lack of proliferation and regeneration of neurons to accomplish correct
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connections. The regenerative response is different between the peripheral (PNS) and the CNS.
Regeneration in the PNS is more successful due to the presence of Schwann cells (SCs), which
provide nutrients, guide and myelinate the peripheral axons and synthesize growth factors.
Moreover, a unique structure exists in the PNS: the bands of Büngner, consisting in clusters of
oriented SCs and their processes, which remain after axon injury facilitating its regeneration.
On the contrary, the predominant glial cells in the CNS are the oligodendrocytes, which
provide axon support and myelinate axons, and the astrocytes, which principal function is to
provide nutrients to the neurons. Oligodendrocytes express inhibitory proteins for axon
growth, such as the myelin associated glycoprotein (MAG) and tenascin R, while SCs lack of
these inhibitory proteins. In addition, astrocytes are activated to clustered layers of hypertro‐
phic astrocytes giving place to the glial scar, which constitutes a physical barrier for axon
outgrowth. Moreover, hypertrophic astrocytes secrete inhibitory molecules such as sulphated
proteoglycans, MAGs, Nogo, etc., constituting a chemical barrier for axon outgrowth [39].
Figure 1. Consequences of neural injury and strategies for repair (from P. J. Horner and F. H. Gage [39], with authori‐
zation).
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In the case of traumatic injuries as TBI, stroke and SCI the primary damage generates an abrupt
loss of cells and may result in the disruption of the blood brain barrier (BBB) and blood spinal
cord barrier (BSCB), respectively. The breach in the BBB and BSCB permits infiltration of
foreign cells such as macrophages and fibroblasts, and inflammatory molecules activating
astrocytes. In the case of neurodegenerative disorders as Parkinson’s disease (PD), the loss of
neurons is not abrupt but progressive, but the injured site is dominated by a toxic microen‐
vironment as well. The neuronal injury and the inhibitory microenvironment result in
degeneration at a cellular level: demyelination, axonal retraction and aberrant sprouting, and
cell death. The tissue engineering strategies proposed aiming to repair injured tissues in the
CNS must take into account these mechanisms of cell degeneration.
Thus, the main difficulty to regenerate neural tissues in the CNS after an injury is the toxic
microenvironment generated and the lack of neuron replacement, although some neurogen‐
esis has been observed after trauma. Indeed, despite the dramatic situation following a CNS
injury, several studies have demonstrated that CNS axons could regenerate with an appro‐
priate microenvironment. A favourable environment for CNS regeneration takes into account
aspects as the normal function of glial cells, a correct system of nutrient distribution, a
permissive physical pathway for axon growth and reconnection and a correct balance and
distribution between inhibitory and promoting molecules for axon regeneration.
4. Cell therapy in the central nervous system
Cell therapy aims to supply the damaged tissue with glial cells, neurons, and even extracellular
matrix components, adhesion molecules and/or neurotrophic factors. Cells could lead to a
neuroprotective effect, help glial and neuronal remodelling, promote angiogenesis and
synaptogenesis and modulate the inflammatory response. A wide range of cells has been
employed to help regeneration in the injured CNS: glial cells, adult stem cells, embryonic stem
cells and pluripotent stem cells [40]; the particular characteristics thereof are discussed next.
SCs are cells that promote regeneration in the PNS because of their ability to generate a
permissive environment for axon regeneration and provide neuroprotection. SCs support
growth and produce neurotrophic factors, including fibroblast growth factor (FGF), neuro‐
trofin-3 (NT-3), brain derived neurotrophic factor (BDNF), nerve growth factor (NGF) and
ciliary neurotrophic factor (CNTF), and secrete proteins such as laminin (LN) to promote axon
growth. Moreover, SCs provide pathways for regenerating axons assisting the growth cone
extension and guidance, and remove myelin debris following damage and remyelinate the
regenerating axons. In some spinal cord lesions, SCs infiltrate into the CNS from the peripheral
ganglions and assist the regeneration process. For this reason, some researchers have investi‐
gated the implantation of SCs in the damaged spinal cord, and they have demonstrated their
ability to promote axonal regeneration and myelination [41]. However, their use to address
CNS regeneration is limited because SCs activate astrocytes, which increase the expression of
inhibitory chondroitin sulphated proteoglycans (CSPGs) for axon regrowth and overexpress
glial fibrillary acidic protein (GFAP) contributing to the formation of the glial scar. Moreover,
Materials for Central Nervous System Tissue Engineering
http://dx.doi.org/10.5772/59339
207
the neuroprotective effect of transplanted SCs is limited because they not prevent degeneration
and secondary injuries. Other glia (astrocytes, oligodendrocytes, and microglia) has been also
studied in connection with CNS regeneration. Implantation of macrophages in the injured
spinal cord has shown some degree of regeneration due to their effect clearing myelin debris
decreasing the inhibitory MAG levels for axons guidance [42]. However, the regeneration
process assisted by macrophages is unclear, because they can inhibit axonal growth after SCI.
On the other hand, the use of other glial cells, including astrocytes and oligodendrocytes, is
usually addressed by employing precursors limited to differentiate to glial cells. These
progenitor cells difficult the formation of gliotic scar than SCs and induce axon regeneration
and remielynation [43].
Olfactory ensheathing cells (OECs) constitute an interesting type of cells in CNS regeneration
strategies; they have been employed in animal models of SCI and stroke with several advan‐
tages over SCs [44,45]. These cells, in their natural environment, guide axons from the PNS to
the CNS, and do not induce unfavourable interactions with the glial scar components.
Furthermore, OECs express many of the same neurotrophic factors and proteins as SCs,
including NGF, BDNF, GDNF, NT-3 and L1, facilitating axon regeneration and providing
neuroprotection. After their transplantation in different SCI models OECs have demonstrated
their ability to generate a more permissive microenvironment; they even lead to a limited
regeneration, electrophysiological and functional recovery [46–48]. Infusions of OECs have
been employed to address stroke, resulting in benefits to repair the damaged cerebral tissue,
providing neuroprotection, facilitating neurite outgrowth, activating stem cells, reducing the
lesion cavity and decreasing cell apoptosis, even improving the neurological function [44,49].
However, the implantation of OECs alone in the nigrostriatal tract of PD models is not
sufficient to promote regeneration and functional recovery, because OECs do not release L-
dopa to stimulate dopaminergic neurons [50]. Nonetheless, their role could be to permit the
reentry of dopaminergic axons into the striatum once they have grown through a guiding
structure, such a peripheral nerve graft [51]. Their transplantation together with other cells,
including dopaminergic neurons derived from neural stem cells (NSCs), has demonstrated
though ability to provide a slight functional recovery in PD models [52]. Moreover, some
studies have employed genetically modified OECs overexpressing some neurotrophic factors
in SCI models, resulting in a modest improvement of tissue sparing and functional recovery
[53]. Some researchers have transplanted OECs addressing spinal cord repair and observed
remyelination of axons, but this could be due to a contamination of the OECs suspension by
other cells such as SCs since myelination by OECs has been debated [54]. OECs have been also
employed in some controversial clinical studies of stroke and SCI, showing some degree of
functional recovery, but these results must be corroborated in further studies [55,56].
Adult stem cells from different origins, including mesenchymal stem cells (MSCs), NSCs and
neural progenitor cells (NPCs) have been transplanted in several traumatic injuries and
neurodegenerative diseases in preclinical studies, and in clinical trials of stroke and SCI [57].
MSCs and NSCs are multipotent cells; the particular feature exploited in MSCs is its ability to
differentiate into cells secreting neurotrophic factors, while NSCs can differentiate in both glial
cells and neurons [58,59]. MSCs have been implanted in the spinal cord, showing the formation
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of bundles that bridge the lesions, even increase the locomotor function, suggesting that MSCs
provide trophic factors and support for host cells and themselves [60]. Meanwhile, NSCs
implanted in the injured spinal cord have eventually differentiated into astrocytes [61], thus
these cells should be stimulated to favour their differentiation into neurons. The implantation
of NSCs in the injured spinal cord may also be combined with growth factors promoting the
neural lineage or limiting the effect of the inhibitory molecules in the environment of the
damaged spinal cord. This technique has been implemented combining NSCs with agonists
of astrocyte differentiation, accomplishing differentiation of NSCs into neurons and functional
recovery after SCI [62]. Furthermore, MSCs and NSCs have been transplanted in ischemic brain
and stroke rat models showing promising results, including stimulation of endogenous cells
and neurogenesis from the SVZ, promotion of angiogenesis, reduction of glial scar, even
functional benefits [63–65]. In addition, MSCs have been tested in a clinical trial of stroke to
prove their safety in humans, showing promising results [66]. MSCs and NSCs have also been
studied to address neurodegenerative diseases, including Huntington’s disease (HD) and PD.
MSCs have demonstrated migration to the injured striatum, neuroprotection through the
release of neurotrophic factors, even functional recovery over months [67–70]. Besides, NSCs
implantation into the striatum has resulted in neuron differentiation and some functional
improvements [71,72], suggesting that infusions of these cells could constitute a possible
therapy for cell replacement in neurodegenerative diseases. In this sense, NSCs have been
employed in clinical trials of both PD and HD, resulting in functional improvements over 36
months and 10 months, respectively [72,73]. However, these cells presented problems to
engraft the lesion site and showed a poor survival. Other types of adult cells such as the adrenal
chromaffin cells and human retinal pigment epithelium cells (hRPEs) have been employed in
clinical trials to restore functions in PD, since they secrete dopamine or its precursor L-dopa,
and can be employed as suppliers of L-dopa in situ. Both adrenal chromaffin cells and hRPEs
have demonstrated modest functional improvements [74,75]. However, these cells have a poor
survival and only a small fraction is able to secrete L-dopa or dopamine, or is secreted in small
amounts.
Embryonic stem cells (ESCs) are derived from the blastocyst and possess interesting properties,
including pluripotency and self-renewal, allowing their differentiation into cells from the three
germ layers. For this reason, ESCs may constitute a source of different cells, including neuronal
ones, with many possibilities in CNS regeneration. ESCs from mouse and human origin have
been employed to address experimental studies in different CNS damages. For instance, ESCs
have been induced to differentiate, preferably, into oligodendrocytes and implanted in the
injured spinal cord of different animal models, including mouse, rats and chick embryos; they
have shown to stimulate remyelination and promote locomotor improvements [76–78]. In
another work, large amounts of motor neurons have been obtained in vitro from human ESCs
and have been transplanted into the spinal cord of chick embryos maintaining their phenotype,
but the potential benefits of the neurons stemming from ESCs require further characterization
[78]. The poor survival of ESCs in the injured spinal cord can be enhanced by the incorporation
of neurotrophic factors, including BDNF [79]. Mouse and human ESCs have also been
differentiated in vitro into dopaminergic neurons, addressing their potential use for PD
treatment [80,81]. These findings have led to the use of dopaminergic neurons derived from
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ESCs in preclinical PD transplants, avoiding immune response, resulting in slight motor
improvements and a reduction of symptoms [82,83]. The use of ESCs is also a promising
approach to address several CNS damages; however, using ESCs requires solving many
problems, such as poor cell survival and low efficacy of transplanted cells, ethical aspects
because of its embryonic origin and the risk of teratoma formation.
As regards induced pluripotent stem cells (iPSs), they do not pose the ethical problems
associated with the use of human ESCs and show a lesser degree of immune response. These
cells are obtained from somatic cells by overexpressing four reprogramming factors (Oct4,
Sox2, Klf4, and Myc), leading to self-regenerative and pluripotent cells like ESCs. These
pluripotent cells may be differentiated into the desirable lineage, including glial cells and
neurons, by adequate molecular stimuli, and can be transplanted to address several CNS
damages. Nevertheless, the use of iPSs gives rise to problems still to be solved, including
teratoma formation, aberrant reprogramming, or presence of transgenes before their clinical
application.
In summary, preclinical and clinical trials have shown that implantation of cells in the CNS
yields transient benefits based on paracrine effects. However, pure cell supply therapy has
brought only modest results lagging behind initial expectations, due probably to a variety of
factors such as a poor cell survival in an aggressive environment and an inappropriate axon
reconnection and guidance.
5. Cues influencing axon guidance and growth
Biomaterials have been studied in a wide range of tissue engineering fields since decades. They
are usually manufactured as scaffolds and their general function is to mimic the specific tissue
and cell extracellular matrix (ECM) during the regenerative process. Scaffolds directly affect
cells behaviour, in terms of their adhesion, proliferation, migration, differentiation, and
maintenance of phenotype. Biomaterials in neural tissue engineering can be tailored to trigger
these effects in cell behaviour as well. In addition, scaffolds in neural tissue engineering can
be useful to guide and stimulate axon outgrowth, provide a neuroprotective effect in the toxic
microenvironment of the injured CNS and support glia migration.
In the last decades, researchers have investigated the cues involved in axon growth and
guidance by several in vitro studies, which are related to cell substrates (structure, composition,
mechanical properties, etc.), physical stimuli (electrical signals and mechanical stretches),
cellular cues (glial and other cell types) and permissive and inhibitory molecules of axon
growth (ECM components, neurotrophic factors, etc.).
5.1. Molecular cues
Cell behaviour including adhesion, differentiation, migration, etc. and particularly, axonal
extension, growth and guiding are regulated by different molecules, which become thus
crucial in the tasks to address CNS regeneration. Axonal extension and guidance is initiated
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by the molecular interaction of microtubules of the growth cone with the surrounding signals
(chemical and physical cues). The growth cone development during axonal sprouting is
influenced by chemical signals, including ECM and cell adhesion molecules and neurotrophic
factors. However, the complex neuronal network within the CNS results from the presence of
promoting (growth factors and proteins) and inhibitory molecules of axonal growth (including
canonical axon guidance molecules (semaphorins, ephrins, etc.), myelin associated glycopro‐
teins (MAG) and CSPGs). This complex neural network of the CNS begins to form at early
stages of embryogenesis and continues through the adulthood. Moreover, some of these
molecules may act as promoters or inhibitory ones depending on the stage of the developing
CNS.
ECM components-based substrates have been employed to obtain scaffolds with binding
moieties for direct cell attachment [84]. The most commonly employed ECM components to
address in vitro studies of axonal growth and guidance include proteins such as collagen,
laminin (LN), fibronectin (FN) and their specific peptides: RGD, GRGDS, and IKVAV, etc. The
ability of these molecules to generate bindings to a number of membrane-bound receptors has
been exploited by several researchers, which have developed ECM components-based
scaffolds to favour neuron attachment and neurite outgrowth including collagen porous
scaffolds [85] and fibrin multichannel conduits [86]. However, the majority of the synthetic [87]
and natural [88] substrates employed usually lack of protein-binding motifs and other
permissive molecules of axon growth such as neurotrophic factors, which may be incorporated
post-processing by different methods including physical adsorption, encapsulation into
substrates, electrostatic interaction, covalent immobilization and cultures of natural or
modified cells with the ability to secrete these molecules. The incorporation of molecules for
cell adhesion improves growth cone attachment, neurite growth rate, branching and extension
compared with the uncoated biomaterials [89–91], even some aspects of neural and glial cells
fate can be enhanced, for example proliferation and migration [87]. The incorporation of cell
adhesion molecules on substrates can be accomplished by different techniques, including
physical entrapment, chemical linking and physical adsorption. These methodologies combine
permissive and limiting pathways for axon guidance, to obtain parallel and preferential
pathways or microchannels for axon growth. Gradients of permissive molecules on substrates
can also be achieved by different techniques including microcontact printing of proteins,
selective detachment of immobilized molecules by laser or electron ablation, among others.
These techniques enhance neural attachment and increase neurite lengths, and even can favour
the orientation of extended axons in the direction of the gradients and/or along the coated
substrates and a bipolar morphology [92,93]. The non-permissive molecules of axon outgrowth
play an important role on forming the correct axonal pathways; for instance, axons can be
grown and guided into channels surrounded by CSPGs, in a similar way than on cell adhesion
molecules [94]. Moreover, parallel axons can be grown in multichannels thanks to a combina‐
tion of permissive molecules forming the axonal pathways and inhibitory ones forming the
limiting regions of axon outgrowth [95].
Peptide motifs can be incorporated to the substrates in similar ways as ECM components, and
accomplishing comparable improvements in cell attachment, neurite length, glia migration
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and orientation of growing axons, since these peptides constitute the functional parts of some
relevant proteins implied in cell attachment. Several authors have demonstrated that depleting
these functional sites of the cell adhesion proteins leads to an abrupt reduction of neurite
lengths and cell migration and the ability of growth cones to turn towards higher peptide
densities [96,97]. Some peptides show the ability to form self-assembled nanofibrous gels, with
fibres sizes of a few nanometres, by the spontaneous organization of the molecules under
physiological conditions, forming non-covalent bonds including hydrogen bonds, Van der
Waals forces, electrostatic forces, etc [98]. This self-organization of peptides leads to hydrogels
with molecular and topographical cues to enhance differentiation of NSCs into neurons despite
astrocytes [98] and neurite extension [99].
Neuronal and glial proliferation differentiation and axonal growth and guidance can be
regulated and promoted by growth factors including FGF, insulin-like growth factors (IGF-1,
IGF-2), vascular endothelial growth factor (VEGF), and neurotrophic factors, including NGF,
BDNF, neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), glial cell-line derived neurotrophic
factor (GDNF), CNTF, etc. These molecules are able to promote the differentiation of embry‐
onic and adult NSCs [100–102] and other adult cells, including MSCs [103] and rat pheochro‐
mocytoma (PC-12) cells [104] into neuronal fates. Several studies have shown that solubilized-
or substrate-immobilized neurotrophic factors produce higher neurite length, cell attachment
and neuron survival [105–107]. Besides, some in vitro studies have shown the ability of
neurotrophic factors to enhance functional connections showing expression of synapses and
different neurotransmitters, even the new-formed synapses presented the ability to respond
to external stimuli [105]. Immobilization of neurotrophic factors and growth factors can be
accomplished by similar methods to those of proteins or peptides, including physical entrap‐
ment, chemical linking and physical adsorption for a controlled release during weeks [106].
Their effects can vary depending on the preparation method; for example, the chemical
immobilization of NGF onto substrates has shown an increment of differentiation into neurons
compared to physical entrapment. Chemical immobilization has resulted in similar neurite
lengths and neuron survival to those studies where the growth factor is daily incorporated
into culture media [107]; this result is interesting to improve the effect of biomaterials with
neurotrophic or/and growth factors for neural implants. Several immobilization techniques of
neurotrophic and growth factors permit to perform gradients thereof on substrates, even into
scaffolds, with an important effect in neurite and axon guidance [107,108]; they have shown
to elicit turning of growth cones and axons outgrowth in the direction of their gradients. The
neuronal behaviour, including neurite outgrowth and length, can be even improved combin‐
ing several neurotrophic and growth factors and modifying the amount of each one. Moreover,
this synergistic effect can be also observed by combining factors and cell adhesion molecules.
The combination of factors allows NSCs to differentiate into several neural or glial lineages,
and particularly some combinations permit to obtain neuronal cells despite astrocytes,
suggesting their potential use to avoid the inhibitory glial scar [109].
ECM components, growth and neurotrophic factors are not the unique molecules employed
to address neurite outgrowth; other molecules including immunoglobulin-like adhesion
molecules (NCAM and L1), receptors (ephrins), neurotransmitters (acetylcholine), etc. have
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also been studied to address neural regeneration. Adhesion molecules as L1 and NCAM show
similar effects on neurite outgrowth and cell viability than permissive ECM components;
however, L1 can induce more the attachment of neurons in detriment of astrocytes compared
with LN [89]. Ephrins have an important role in axon growth during CNS development, but
in the adulthood, they become inhibitory of axon outgrowth. Curiously enough, on substrates
with gradients of ephrins axons grow in the direction of higher gradients but growth stops at
higher densities, showing the ambiguous effect of these molecules in axon growth and
guidance [110]. Neurotransmitters have an important role in neuron communication and
transmission of electrical impulses and, as a consequence, these molecules are vital to obtain
a correct synapse formation and function and in neuron survival. Neurotransmitters can be
biomimicked by chemical compounds and incorporated to different substrates, showing
improvements in neuron survival and neurite extension, even similar to cell adhesion mole‐
cules [111].
5.2. Topographical cues
Cell differentiation is a process dependent of external stimuli and is well known that cell-
substrate interaction and particularly topographical cues are important in this cellular
behaviour. Bellamkonda discussed the anisotropy of both molecular and substrate topography
as an important cue to obtain faster and more orientated axon regeneration and to direct
growth cones following a unique direction [112]. This idea has resulted in a wide variety of
investigations, where researchers have studied axon outgrowth, both in vitro and in vivo, on
anisotropic substrates such as surface patterns, fibres and channels. Different 3D structures
with pronounced anisotropy are obtained by different micro and nanofabrication techniques.
For example, nanofibres are usually obtained and aligned by electrospinning techniques, while
microfibres are fabricated by extrusion with different morphologies [113,114]. Microchannels
are principally made by moulding employing fibres templates or other techniques such as laser
irradiation, freeze-drying, dipping and ion capillarity [88,115,116]. Nano and micropatterns
are fabricated by common techniques such as lithography, photolithography, moulding
templates, reactive ion etching, etc. [117], which allow to obtain structures alternating permis‐
sive axon pathways (grooves) and high ridges to separate them.
Silicon-based  materials  such  as  polydimethyl  siloxanes  (PDMS)  have  been  commonly
employed  to  develop  micropatterns  [118].  Researchers  have  studied  exhaustively  these
systems to optimize their  dimensions (groove depth,  width and space)  to enhance axon
growth and guidance. Axon alignment and outgrowth is increased as a response to greater
depths of the grooves because cell bodies are restricted to the grooves, avoiding neuronal
crossing between grooves. Several studies have stated that an optimal groove width of 20
μm enhances neurite extension and achieves a bipolar structure oriented in the direction
of the grooves and with a significant reduction in neurite branching [119]. Other investiga‐
tions gave similar results using stem cells and neuronal lines, including human neural stem
cells  [120]  and  PC-12  cells  [121,122].  These  studies  show  a  similar  behaviour  of  axons
outgrowth in the micropatterned substrates:  the channels width must be enough to host
the neuronal body but not too much to permit neurite hyperbranching, yielding neuron
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bipolar and oriented structure. These findings are conditioned to the sizes of different parts
of the cells: neuronal bodies are in the range of 10-20 μm, growth cones about 5 μm, while
axons and focal  adhesions show sizes  about  1-3  μm [123].  However  some studies  have
shown unexpected neuron morphologies on microgrooves,  in which neurons can bridge
between adjacent channels with no underlying support [124].
Some researchers have exploited the idea of obtaining substrates with topographies that mimic
the glial scar environment (combination of permissive and inhibitory cues on axon pathways),
for example studying the behaviour of co-cultures of astrocytes and neurons. This idea was
addressed by Krsk et al. [125], who fabricated silicon wafers with discrete polyethylene glycol
(PEG) grafts by electron-beam, which forms an inhibitory region similar to the glial scar. These
authors obtained parallel silicon 3 μm-channels separated with PEG lines and silicon arrays
with different distances between PEG spacers (1, 2, 3, 4 and 10 μm). They determined that
astrocytes and mouse dorsal root ganglia (DRGs) neurons grew parallel to the PEG lines onto
the grooves forming elongated structures and oriented actin filaments and neurites, respec‐
tively. Furthermore, both neurites and astrocytes grew only onto above distances of 2 μm
between PEG spacers, but astrocyte adhesion and spreading were comparable to the unpat‐
terned silicon when the arrays were 10 μm long between PEG spacers.
Nanopatterned substrates (submicron features) provide differences in neurite growth and
alignment with respect to the micropatterns, since the effect of nano-size features can be
considered as a roughness phenomenon on cell behaviour. The nanostructured materials
increase cell-substrate interactions, promoting cell adhesion and hosting neuronal processes,
but not cellular bodies. Nanostructured topographies mimic the structure and dimensions of
ECM components and chemicals; they cannot host axons and neural bodies, but their sizes are
in the range of the ECM components (organized proteins and polysaccharides) involved in
cell attachment, spreading and migration, including fibronectin fibrils (about 100 nm), actin
filaments and neurofilaments (10 nm) [123]. Several techniques have been developed to obtain
them: electron-beam lithography to obtain roughnesses above 3 nm, chemical and electro‐
chemical etching with motifs above 2 nm and multiphoton excitation to address greater
structures with 250 nm. Some studies have found that rough surfaces improve cell adhesion
compared to the smoothest ones, in which growth cones reach even half their growth [126].
However, nanogrooves lead to less axon guidance than micropatterns because all somas and
axons grow along the plateau and only the smallest axons are suitable to be aligned [127].
Nanofibres constitute an interesting nanostructure to address neural cell attachment and axon
outgrowth because most of the ECM proteins assemble naturally into fibres with diameters at
the nanometric scale in the physiological environment. Nanofibres technologies permit to
obtain 3D structures or scaffolds and not simple superficial topography or roughness, which
differentiates these substrates from the above mentioned superficial micro and nanopatterns.
Researchers have developed different processes to obtain them, including phase separation,
electrospinning and self-assembly of peptide nanofibres (SAPNs).
Phase separation allows obtaining fibres between 50 and 500 nm, depending on the process
parameters (temperature, polymer concentration, and solvent-polymer system). This method
is achieved by several solvent-removal steps with temperature shifts of a polymeric solution,
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obtaining porous or fibrous structures (both of them interesting structures for different neural
tissue engineering problems). These nanofibrous scaffolds provide a substrate for cell differ‐
entiation of neural lineages, even neurite outgrowth can be accomplished [128]. However, this
nanofibre fabrication method shows several disadvantages because it employs large amounts
of solvents and prevents to obtain aligned fibres, which limits their potential uses to address
the orientation of glial cells and neurites.
Electrospinning is another current and interesting methodology to obtain nanofibres for neural
tissue engineering. It is quite simple and permits to achieve nanofibres with diameters at the
nanometric and micrometric scale. In addition, their operation parameters allow manufactur‐
ing a wide range of fibrous morphologies including random and aligned fibres and more
complex and precise structures. The principle of the electrospinning process consists in the
extrusion of a polymer solution through a small orifice (with the help of a pump pushing a
syringe piston towards its needle) at high voltages, and the evaporation of the solvent as the
jet is projected onto a metallic collector yielding a fibre that superposes with time forming a
mat. Size and morphology of the fibres can be modified by varying operation parameters such
as polymer concentration, viscosity, polymer-solvents interaction, distance from the collector,
the applied voltage and external variables (temperature and humidity). The basic electrospin‐
ning process can be easily modified to obtain other fibrous disposition and morphologies:
rotating drum collectors or two spaced collectors allow obtaining aligned fibrous tubes,
crosslinking agents permit to fabricate polymeric networks, salts may be used to obtain porous
fibres, and the most advanced electrospinning processes allow to fabricate fibres structures
with a nanometric precision. This technique is able to render fibre mats (membranes) of a large
amount of polymeric compositions, both synthetic and natural. The most employed synthetic
biomaterials in neural tissue engineering are the family of aliphatic polyesters including
poly(L-lactic acid) (PLLA), polyglycolic acid (PGA) and poly-ε-caprolactone (PCL), which are
interesting biopolymers to be used in implants for neural tissue engineering for their biode‐
gradability; furthermore, PLLA and PCL are approved by the Food and Drug Administration
(FDA) for uses in some clinical methods. However, a wider range of synthetic polymers has
been studied as electrospun substrates for axon outgrowth and guidance, such as polyamides,
polyacrylates, polyacrylic acids, polydioxanone (PDS), etc. These synthetic polymers can
support well glial and neural cells, in general, but they show different effects over cell
behaviour due to their discrepant properties. On another hand, some researchers have
developed methodologies to obtain electrospun fibres from natural polymers such as collagen,
gelatine, chitosan and hyaluronic acid, because they form part of the tissues and, as a conse‐
quence, they have similar mechanical properties and cells recognize their domains easier than
in the synthetic ones. However, natural polymers generally present poor mechanical proper‐
ties and the electrospun fibres obtained from them show the limitation of handling for clinical
uses. In addition, these materials present high costs, low reproducibility and may contribute
to the immunogenic response. In order to meet the good mechanical properties and reprodu‐
cibility of the synthetic materials and the major biocompatibility of the natural ones, electro‐
spun mats of composites from synthetic and natural polymers (gelatine/PCL, collagen/PCL,
PLLA/laminin, etc.) have recently been developed. Another option is to biofunctionalize
synthetic fibres with ECM components (collagen, fibrin, etc.) by covalent binding or physical
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adsorption; these biofunctionalized fibres enhance biocompatibility, neurite extension, and
glial cell migration and alignment [91,97].
Figure 2. Topographical motifs included in the biomaterials usually employed in CNS regeneration. A) Typical con‐
duits based on an external channel and an inner matrix for peripheral nerve and spinal cord regeneration (from I. P.
Clements et al. [116] with authorization). B) PC-12 cell growing along a microopatterned substrate (from M. J. Maho‐
ney et al. [122], with authorization). C) Multichannel poly (ethyl acrylate) scaffold, inset: detail of the multichannel
scaffold cross-section (own our group). D) Microfilament of polycaprolactone obtained by micro-extrusion (own our
group). E) Crosslinked hyaluronic acid scaffolds with interconnected porous structure (own our group). F) Poly (ethyl-
acrylate)-based scaffolds containing interwoven microchannels (own our group). G) Aligned electrospun fibres of pol‐
ylactic acid (from J. Xie et al. [113], with permission).
Electrospun scaffolds have been employed as artificial matrices for neurons and glial cells. The
most common biodegradable synthetic biomaterials, performed as electrospun scaffolds, show
good cytocompatibility and they are even more biocompatible than as flat substrates [129].
Some researchers have investigated cell differentiation in different electrospun fibres and have
reported differentiation of NSCs and ESCs to neural lineages [130,131]. More in detail, others
have concluded that fibre alignment does not influence the NSCs differentiation to a neuronal
lineage, which does depend on the electrospun fibres diameter, because fibres in the nano‐
metric scale enhance NSCs to neural lineage whereas the micrometric ones do not [132]. Similar
studies with ESCs have demonstrated that both, random and aligned fibres are suitable for
cell differentiation to a neural lineage; however, only the aligned fibres inhibit astrocyte
differentiation [131]. This interesting result may be useful in order to employ aligned fibres as
substrates for ESCs supplying neurons and inhibiting the glial scar formation in some CNS
injuries. Other studies have shown that electrospun scaffolds with aligned fibres enhance a
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bipolar morphology of glial and neural cells and an extension of axons, even DRG ganglia may
be oriented in the direction of electrospun fibres. In addition, neurites grow faster and longer
in the aligned fibres than in the random ones [91,133].
5.3. Cellular cues
The role of glial cells in the regeneration of the injured CNS is crucial because they exert several
functions over neurons in the healthy and developing CNS. Glial cells can be permissive or
inhibitory of axon outgrowth; even they change their roles in the developing, adult or injured
CNS. The most studied glial cells to address axon guidance include SCs, astrocytes and
olfactory ensheathing cells/olfactory nerve fibroblasts (OECs/ONFs).
SCs promote the axonal cone growth and show a neuroprotective effect in the regenerating
axons by the release of some neurotrophic factors in the injured PNS. This property in the PNS
environment has been widely explored to address axon outgrowth in the CNS. The principal
role of SCs involves myelination and ensheathing the peripheral axons, but they produce
MAGs, which are inhibitory of neurite outgrowth and hyperbranching. Some authors have
studied the influence of SCs in axonal extension in vitro, showing that aligned monolayers of
SCs directly affect neurite outgrowth and alignment without the help of other topographical
cues [134].
CNS glial cells regulate several functions of neurons; for this reason, these cells have been
studied to address their effect in neurite growth. The most widely studied CNS glial cells are
the astrocytes, which main function is to provide nutrients to neurons. Astrocytes have been
reported to be appropriate glial cells to differentiate neural progenitor cells (NPCs) [135]. Some
authors have cultured neurons on monolayers of previously aligned astrocytes by several
techniques such as electrical fields [136] or topographical cues [137], demonstrating that the
bipolar morphology of astrocytes is able to enhance neurite outgrowth and alignment, even
neurite outgrowth can be compared to what happens onto micropatterned proteins. However,
co-cultures of neurons and random astrocytes have not demonstrated important changes in
neurite outgrowth, because the astrocytes are in a multipolar shape characteristic of the
hypertrophied ones, which constitute the glial scar [138].
OECs constitute one of the most promising adult cell types in order to address CNS injuries.
These  cells  present  some  similarities  with  SCs  and  astrocytes  (molecular  expression,
morphology and functions).  However,  they are the unique glial  cells  with the ability to
cross the PNS-CNS transition zone helping the olfactory axons outgrowth from the nasal
epithelium to the olfactory bulb. Their ability to interact with both nervous systems has
given rise to the idea that OECs may be able to regenerate axons in the presence of gliotic
components. In this sense, authors have demonstrated how OECs enhance neurite exten‐
sion and increase  the  amount  of  axons  in  gliotic-based substrates  such as  myelin,  even
extension and neurite density resulted similar than using permissive substrates for axon
growth such as LN [139]. Co-cultures of cortical neurons with aligned OECs have shown
higher neuronal lengths and similar alignment of neurites than with astrocytes, but OECs
lead to a more bipolar morphology of neurons [140].
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Glial cells act on neurite outgrowth and neuron alignment by means of different cues, which
include their own topography and molecular cues related with the released inhibitory and
permissive molecules. The effect of molecular components has been largely investigated as
commented above, but the influence of cell topography is still a rather unexplored phenom‐
enon. A few investigations have addressed the effect of cell topography as an independent
factor in neurite alignment and outgrowth by original methods. The methodology employed
consists in obtaining reliefs of a substrate that mimic the shape of different cells, employing
different techniques such as polymerization and lithography of masks of cellular features
obtained by CAD software or impression of cell replicas. Normally, the biomimetic reliefs are
formed by bipolar and oriented morphologies to enhance neurite outgrowth and alignment
and the most common cells-masks include SCs, astrocytes and endothelial cells morphologies.
Aligned cellular motifs of SCs have an influence on neurite alignment and increase their length
compared to flat substrates and random motifs, even perpendicular reliefs have an inhibitory
effect in axon outgrowth [141]. Although astrocytes and endothelial cells can enhance neurite
alignment too, SCs have improved the most these aspects of neurites, higher degrees of
alignment and sizes of their dimensions (weight, length and height), in comparison to
astrocytes and endothelial cells [142].
5.4. Electrical cues
As is well known, electrical voltages play an important role in cell behaviour. Particularly, the
transmission of information between neurons is accompanied by electrical changes in their
environment; this phenomenon is known as action potential (AP). Electrical stimuli are
produced by the existing voltage gradient across the cell membrane and the complex equili‐
brium of environmental and cellular ions and ionic channels across the membrane. The steps
of the process include depolarization of the neural membrane as a consequence of the stimulus
received by dendrites of a neighboring neuron, subsequently the Na+channels open and if there
are sufficient opened channels the entering flux of Na+modifies the cell membrane potential.
The following step includes the repolarization of the membrane by the opening of the K
+channels, which act slowly and restore the original action potential. However, before reaching
the normal membrane potential, neuron is hyperpolarized preventing it from receiving
another stimulus and neuron cannot generate another AP during a brief time, ensuring that
signals travel always in a unique direction.
Electrical stimulation of neural cells has led to the development of new frontiers for neural
tissue engineering in the recent decades, including investigations of new conductive bioma‐
terials and fabrication of electrodes to address several damages in the CNS. Actually, the efforts
have focused on the study of conductive polymers for their electrical conductivity combined
with their characteristics as organic polymers. The electrical properties of these polymers are
due to the presence of loosely held electrons in their backbones that form conjugated π bonds,
and with the help of doping chemicals the polymer can be negatively or positively charged.
Traditionally, dopant agents employed have been inorganic compounds such as ionic species
(chloride, perclorate, iodine, etc.). However, the introduction of active biological dopants is
more attractive from the point of view of biomedical applications [143]. The most commonly
Cells and Biomaterials in Regenerative Medicine218
studied conductive polymers include polypirroles (PPy), polyaniline (PANI) and polythio‐
phene derivatives, specially, the poly (3, 4-ethylenedioxythiphene) (PEDOT), but other
emergent materials as piezoelectric polymers and carbon nanotubes and nanofibres (CNTs
and CNFs) as fillers are promising to develop conductive polymers for neural tissue engi‐
neering. Several studies have shown that PPy are biocompatible with different cell types [144]
and, particularly, with neural cells [145]. PANI and PEDOT as conductive polymers for general
tissue engineering applications have been less studied than PPy ones, but in the recent years
they are more investigated for these purposes. Recent studies have demonstrated the absence
of cytotoxicity of PANI and PEDOT by in vitro studies, showing the biocompatibility of these
alternative biomaterials [146,147]. Moreover, the tissue response of these three conductive
biomaterials has been studied preliminary in some in vivo studies, resulting in non-toxic effects
and with an acceptable inflammatory response [148–150].
External electrical stimuli can be applied to cells or tissues to produce an artificial AP leading
to electrical changes in cells; this phenomenon is termed as electrical stimulation. Electrical
stimulation can influence cellular activities such as proliferation, migration, differentiation,
extension of processes and protein expression [151–153]. Just as other cells, neuron activity can
be affected by electrical fields, both direct and alternate currents (DC and AC, respectively).
Some works have shown how an electrical stimulation influences the direction and extension
of neurite outgrowth [148,153] and the alignment of other cellular types such as astrocytes as
well [154]. In other studies, the electrical stimulation has been found to increase neurite
extension in differentiated PC-12 cells cultured on PPy films [155]. Most recent studies have
corroborated the enhancement of neurite outgrowth with electrical stimulation in other cell
types and different conductive biomaterials, for example NSCs on PANI [156], cochlear neural
explants on PPy [157] and DRG explants on PPy [158]. In addition, these works have demon‐
strated, as Patel et al. [159] suggested, that one explanation for the increment in neurites length
observed is the electrophoretic accumulation of proteins on the surface of the substrate.
As stated previously, CNTs and CNFs are an emergent and promising group of conducting
materials for neural tissue engineering. CNTs are composed of rolled structures of sheets of
graphene, either single-(SWCNTs) or multi-walled (MWCNTs). The most relevant properties
of these materials are their ability to conduct electrical stimuli, form structures with a very
large exposed surface per volume unit, and good mechanical properties (strength, flexibility,
ductility, etc.). The first experiments with CNTs showed that they are cytotoxic when they are
in suspension in a cell culture; nevertheless, posterior studies did not show any cytotoxicity
when they are immobilized in the culture [160]. This fact meant the beginning of their use in
tissue engineering, and for this purpose, it was necessary to obtain CNTs with higher purity
and fabricate more soluble CNTs by functionalization of their surfaces. Other novel conducting
polymers are the piezoelectric ones, which have the ability to generate electrical stimuli by the
help of small mechanical deformations, being the application of external stimuli unnecessary.
The most common piezoelectric polymer is the poly (vinylidene fluoride) (PVDF). This
material has demonstrated good attachment and proliferation of neural cells when it is
combined with l-lysine [161]; even neurite outgrowth can be enhanced compared with non-
piezoelectric materials [162]. Unfortunately, piezoelectric biomaterials have the drawback of
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not allowing the external control of the electrical stimulation, for what it seems preferable to
employ conducting polymers in neural tissue engineering.
Conducting polymers possess a high degree of conjugated bonds providing them rigidi‐
ty, insolubility and difficult processability, for what these polymers may be transformed or
employed  in  composites  with  others.  Besides,  they  are  usually  non-biodegradable  and
usually offer poor biocompatibility; for these reasons some researchers have investigated
the possibility of obtaining conducting biodegradable biomaterials by different techniques
including polymerizations that form degradable linkages, blending conductive polymeric
segments  with  biodegradable  polymers,  and fabrication of  copolymers  of  biodegradable
monomers  and  conductive  biostable  ones  [163,164].  With  the  aim of  improving  neurite
outgrowth and alignment of cells,  bioactive molecules such as neurotrophic factors have
been immobilized on conducting polymers [165], their topography has been modified by
surface treatments to generate microchannels [166] or they have been electrospun to obtain
nanofibrous matrices [158].
5.5. Mechanical cues
The CNS is one of the softest tissues in the body, with elastic modulus between 0.1 and 10 kPa
[167]; others, more rigid as bone and connective tissues, present higher elastic moduli ranging
15-30 MPa and 100-1000 kPa, respectively [168]. Rigidity has an important role at early stages
of embryogenesis and development of tissues, and particularly in the CNS, since cells regulate
the formation of ECM components and their migration by mechanical cues. The rigidity of the
brain increases with aging, and the highest elastic modulus of the nervous system tissues
corresponds to the spinal cord [169]. This accounts for the modulation of the differentiation of
neural precursors into glia or neurons by changing the substrate’s rigidity; for example, ESCs
differentiate into glia in soft substrates whereas they do to neurons in more rigid ones [170],
and NPCs and NSCs show a similar behaviour, differentiating preferably into neurons on
softer substrates with moduli between those of the neonatal and the adult brain [169,171].
In general, axon extension increases in softer substrates, so elastic biomaterials are more
suitable to address axon regeneration. The most commonly employed substrates with
modulated stiffness in neural regeneration are gels as hyaluronic acid, fibrin, polyacrylamide
and PEG due to their mechanical properties similar to the CNS tissue. Similar trends in axonal
extension and branching have been observed in different types of neurons: the softer or more
elastic substrates generally increasing neurite length, neuron attachment and branching
compared to harder ones [170,172,173]. However, axonal extension decreases in very soft
substrates, when they present elastic moduli much lower than that of the CNS tissue [174,175].
Co-cultures of astrocytes and neurons on hydrogels with tuneable mechanical properties have
shown that, unlike neurons, astrocytes attachment decreases on soft substrates. This interest‐
ing result has highlighted the beneficial uses of soft substrates to address CNS injuries with
presence of glial scar [170]. However, neurons have shown good attachment and large neurite
extension and branching cultured on substrates, such as PDMS, which possesses higher elastic
modulus than CNS tissue, suggesting that neuronal attachment depends on substrate chem‐
istry too [176].
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In the latest stage of embryogenesis and during the maturation up to the adult CNS, axons are
submitted to great strains resulting in abrupt changes in their extension. The knowledge of
this natural phenomenon has led to investigate how strain can influence axon extension. As
an example, axon outgrowth has been studied in engineered bioreactors with the ability to
stretch axons on permissive and flexible substrates such as collagen. The normal axon
outgrowth is limited to 1 mm/day by the synthesis and transport of proteins and structural
components to permit the extension of growth cones. However, cultures of DRG on collagen
in a stretch-grown bioreactor and applying a constant strain of 1 cm/day have demonstrated
that axons can grow up to 5 cm in only 8 days, which is a much longer extension than that
reached by conventional therapies in the regeneration of CNS tracts (2-3 cm). Moreover, the
stretched axons maintained their typical cytoskeletal proteins along them and an appropriate
structure in their cross section [177], even the electrical signals showed normal action potentials
due to the increment of the K+and Na+channels density [178]. Cyclic strains can influence
neurite outgrowth just as constant ones. Cultures of neural cells with cyclic strains have
demonstrated a synergistic effect of applied strain and cycles frequencies. This effect has been
studied in cultures of PC-12 cells on PDMS substrates with cyclic stretch and strain levels of
4, 8 and 16% and strain rates of 0.1, 0.5 and 1 Hz, showing that only two operation conditions
enhance neurite density, length and orientation [179]. In contrast, other operation conditions
seem to inhibit neurite length, density and orientation compared to static substrates.
5.6. Physical and chemical cues
Some investigations are related to the study of the effect on neural cells of surface properties
of biomaterials such as charge, functional groups density and wettability. Surface wettability
can be modified by several techniques such as plasma polymerization, even surfaces with
gradients of wettability can be obtained. In works on the effect of surfaces with uniform or
graded wettability on hippocampal neurons it can be observed that graded substrates and
particularly their most hydrophilic regions show an increased cell density, longer and faster
development of the processes than uniform substrates and hydrophobic regions [180]. The
surface gradients seem to promote interactions between neighbouring cells and the develop‐
ment of neuronal networks. Similar results were found by culturing PC-12 cells onto poly‐
ethylene surfaces with wettability gradients prepared by a corona discharge treatment [181]:
cell density was the highest at intermediate wettability of 55º but the length of neurite processes
increased on more hydrophilic regions, suggesting an important role of surface hydrophilicity
on the differentiation of cells into neurons. Different gradients of wettability on the surfaces
of a substrate can be obtained by self-assembled monolayers (SAMs), by the addition of
different siloxanes with methyl-terminated molecules. On these substrates, PC-12 cells can
differentiate to neurons with neurotrophic factor-free medium, and the differentiation is
enhanced on substrates with higher surface wettability. These results suggest the importance
of mechanical, chemical and spatial cues in neural fate [182].
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6. Biomaterials for traumatic brain injury and similar neuronal damages
Traumatic brain injury and similar brain damages including hypoxia or stroke produce an
abrupt loss of neuronal and associated glial population at a primary stage. This initial damage
is followed by inflammatory processes leading to a secondary loss of neurons and glial cells
and the astrocyte activation forming the inhibitory glial scar for axon outgrowth. Brain tissue
damage constitutes, thus, a multistep process leading to the formation of a lesion cavity and
necrosis, surrounded by glial scar avoiding axonal regrowth and, as a consequence, the
successful healing of the damaged tissue. The cavity generates a loss of brain tissue forming a
hostile region to support cells that, together with the inhibitory glial scar, avoid its regeneration
leading to psychiatric and neurological symptoms. The inhibitory nature of the CNS due to
the presence of astrocytes and oligodendrocytes, the lack of enough neurogenesis niches and
the toxic microenvironment after brain injury avoid the regeneration in the brain.
The justification for employing biomaterials after brain damages is principally this lack of cell
support, and biomaterial scaffolds should be able to mimic the natural environment of cells
promoting their attachment and/or entrapment aiding the regenerative process. Scaffolds can
lodge cells in a tridimensional context, allowing diffusion of nutrients and acting as substrates
to enhance cell survival, neurite extension, axon regeneration and cell infiltration. The selection
of the biomaterials in brain regeneration is based on the principles to achieve neuroprotection
of the surrounding native tissue avoiding the secondary cell death, and neuroregeneration of
the damaged tissue to restore functions.
Normally, the use of natural polymers is preferable rather than synthetic ones because most
of these biomaterials are present in the tissues and their effects are well known; however, many
synthetic biomaterials have though a good integration with brain tissue and present some
advantages respect to the natural ones, including lower cost, enhancement of mechanical
properties, handling, etc. The functional groups within the employed biomaterials can affect
cell attachment, since surface charge, hydrophilicity and hydrophobicity are determinant on
the biocompatibility of the biomaterials. Cells prefer to attach on positive surfaces because
their membrane contains residues of sialic acid, which provide a net negative charge. On the
other hand, substrate hydrophilicity and hydrophobicity govern the formation of non-specific
protein layers, which can cause inflammation, and the conformation of proteins involved in
cell attachment.
The device size is an important parameter in order to cause the minimal damage due to the
invasive surgery. Besides, the biomaterial morphology is crucial to ensure nutrient transport,
vascularization, cell attachment and colonization in the inner structure. Moreover, ideal
structures should provide high surface/volume proportions (interconnected porous scaffolds,
microspheres, nanofibres, etc). The surface of substrates plays also an important role in cell
attachment and behaviour (view previous section). Mechanical properties such as elasticity
influence cell spreading; thus, softer substrates (mimicking the mechanical properties of the
brain) can favour the differentiation of neural precursors and NSCs into neural lineages. From
the biological point of view, a basic requirement of any material used is obviously its biocom‐
patibility, avoiding adverse cell response, which leads to the formation of gliotic scar and/or
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acute inflammation. Thus, researchers look for materials not inducing astrocyte reaction and
showing a modest inflammatory process. Besides, the biomaterial should preferably biode‐
grade without leaving any foreign residue as the regenerating tissue replaces it.
Preclinical strategies using biomaterials to address brain damages should satisfy these
requirements and provide brain neuroprotection and neuroregeneration. Most of the studied
biomaterials for brain regeneration include in situ formed gels [183] and porous interconnected
scaffolds [184]. In addition, other types of structures such as fibres [185], aligned microchannels
and interwoven microchannels have been also proposed [186].
6.1. Natural biomaterials
Natural polymers are similar to some substances present in tissues (polysaccharides, proteins
and glycosaminoglycans), even many natural biomaterials form part of the ECM compounds
such as collagen and hyaluronic acid. Therefore, implant devices based on natural polymers
have in general high biocompatibility. Moreover, in some cases, they may provide signals to
cells improving cell-substrates interactions and modeling cell behaviour. They are usually
biodegradable by enzymatic degradation, making them good candidates for implantable
devices in brain.
A commonly employed biomaterial for tissue engineering is collagen, which is a fibrillar
protein forming part of the ECM compounds. Collagen is a natural biodegradable polymer
and shows good biocompatibility when it is employed for brain regeneration purposes. This
natural polymer has been implanted in the brain forming interconnected porous scaffolds or
in situ gels. Several authors have employed commercial scaffolds from decellularized and dried
tissues from human donors, maintaining the natural structure of collagen tissues [187–189].
Moreover, collagen may be tailored by different processes, such as freeze-drying, in order to
obtain porous scaffolds, which are more suitable for cell ingrowth [190]. However, this
biomaterial alone does not reduce the size of the lesion cavity nor produces significant
functional recovery [187]. The implantation of crosslinked scaffolds based on mixtures of
collagen and glycosaminoglycans (GAGs) such as hyaluronan, chondroitin sulphate and
heparan sulphate seems to lead to some functional recovery [188]. Freeze-dried collagen-GAG
scaffolds with 140 μm-pore diameters and porosity around 96% remained in rat brains 28 days
after implantation, reduced the lesion volume, increased the amount of cells in the surrounding
tissue, promoted the secretion of neurotrophic factors such as GDNF and BDNF by the host
cells and stimulated neurogenesis of neural precursors from the SVZ. Consequently, the
inflammatory response of brain tissue was not excessive, promoted cell proliferation and
differentiation of migratory neuroblasts, suggesting certain degree of regeneration. Moreover,
the results from different tests regarding behaviour, motor and reflex response in animals
(adhesive-removal tests and neurological severity scores-NSS-) suggest that animals with
biomaterial implants show less neurological deficit than the untreated groups; therefore,
collagen-GAG scaffolds achieve some functional recovery without the need to combine with
other therapies including drug release or cell entrapment. Some brain functional recovery can
be accomplished combining collagen-based interconnected porous scaffolds with seeded and
expanded MSCs. MSCs have the ability to release neurotrophic factors and migrate into the
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lesion boundary zone, remodelling the injured brain tissue and reducing the lesion cavity [188–
190]. The implantation of these hybrids in the brain of rats and mice promoted angiogenesis
by the formation of new vessels, and increased the neural fibre length in the scaffolds. Some
neuroregeneration was assessed by sensomotor functional recovery and improvements in
spatial learning, which are higher compared with separated treatments, due to the beneficial
effects of the collagen substrates to support and localize cells and the molecular signals
produced by MSCs [187]. The use of this biohybrid system implies an important limitation that
is the need for open-surgery to implant it in the brain. To avoid such invasive process, an in
situ gelation can be followed, since collagen is able to form gels at physiological temperatures.
For example, mixtures of collagen with NSCs and proteins (fibronectin and laminin) have been
gelled in situ and employed in the brain. This post-implantation gelation of collagen with NSCs
allows cells to distribute widely in the lesion site, oppositely to what happens when NSCs are
implanted alone. The incorporation of proteins improves transplanted cell survival during
weeks, and the use of laminin shows the highest levels of NSCs survival, which is related with
the improvements of cognitive functions suggesting a higher grade of neuroregeneration [183].
Hyaluronic acid (HA) is a negatively charged GAG with a high molecular weight and an
abundant ECM component found in the CNS tissue. As biomaterial, it presents interesting
properties for neuroregeneration purposes, including biocompatibility, biodegradability and
a high degree of swelling. HA products from the degradation process stimulate endothelial
cell proliferation and migration promoting angiogenesis. The high degree of swelling permits
to accommodate and cover entirely the lesion cavity, conferring it mechanical properties
similar to those of the brain tissue and allowing nutrients, ions and solutes transport. Besides,
HA of high molecular weight has an anti-inflammatory effect, allowing the control over
microglia activation and avoiding foreign body reaction. The ability of HA to absorb large
amounts of water allows it to be cross-linked under diluted solutions, obtaining hydrogels.
HA cross-linked hydrogels and a successive step of freeze-drying allow obtaining porous
structures, which can be from nanoporous to interconnected macroporous (scaffolds) struc‐
tures. The formation of each structure depends on the crosslinking conditions and is due to
the freeze-drying of the water absorbed by the molecule. Thus, the principal advantage of
porous scaffolds is to increase the surface area for cell attachment and ingrowth. HA-based
hydrogels containing pores up 60 μm implanted in the rat brain have demonstrated their
angiogenic activity, inhibition of formation of on the one hand a glial scar and on the other of
a secondary cavity or an envelope by hyperplasia or connective tissue and cell aggregation
[187]. The major limitation of HA is its poor cell adhesion; subsequently, it is usually employed
with adhesion molecules or in combination with other polymers. For example, HA-based
scaffolds with immobilized LN have demonstrated improvements in the astrocyte response
and the stimulation of neurite ingrowth, suggesting that HA-based scaffolds with these
proteins promote neuroregeneration [191]. HA-based scaffolds with peptides such as IKVAV
show similar effects than with laminin immobilization, that is, a limited and localized inflam‐
matory response, angiogenesis, neurite ingrowth and the complete integration of the scaffold
within the host tissue [184]. In order to obtain interconnected porous scaffolds, HA may be
copolymerized with adhesive molecules. Therefore, scaffolds based on copolymers of HA and
poly-d-lysine enhance cell migration and attachment without increasing inflammatory
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response when they are implanted in rat brains [192]. Poly-d-lysine in combination with HA
grants scaffolds with a more positive net charge, which improves cell attachment as mentioned
above. The limitation to implant HA scaffolds is again the invasive surgery required, but HA
can be combined with other polymers to form gels in situ. For example, combining methylcel‐
lulose with HA thermoresponsive gels can be obtained, which, similarly to HA scaffolds,
reduce the lesion cavity and attenuate microglia activation [108]. The combination of HA
hydrogels with neuroprotective molecules, such as erythropoietin (EPO), promotes migration
and proliferation of NSCs and NPCs from the SVZ, reduces apoptosis and increases the amount
of neurites, suggesting some neuroregeneration in the injured cortex [193]. The neuroregener‐
ative effect of HA biomaterials can also be promoted by attaching to the hydrogel receptor
antibodies of inhibitory molecules for neural growth, such as NoGo [194].
Chitosan is derived from the alkaline deacetylation of chitin, a natural polysaccharide found
in crab shells and many shellfish. The degree of deacetylation produces a positive charge and,
consequently, increases cell attachment, reduces inflammation and enhances biocompatibility.
Chitosan is naturally degraded by the effect of lysozyme and its biodegradability can be
controlled by the degree of deacetylation. It has shown good biocompatibility with neurons
and glial cells in vitro, although the viability of neural cells should be improved [195]. Chitosan
becomes a thermally responsive gel with glycerolphosphate salt at physiological temperatures,
and the gelation process forms a hydrogel able to attach cells and transport nutrients, even the
degradation process allows cell infiltration. This property has been exploited to obtain gels in
situ for brain repair avoiding invasive surgeries. However, the implantation of chitosan gels
into rat brain has been found to produce a high inflammatory response by activation of
macrophages, leading to the complete phagocytation of the biomaterial in a few days [196].
The activation of macrophages is due the receptor-mediated binding of N-acetylglucosamine,
and this effect should be controlled for its future application in the human brain.
Methylcellulose is a cellulose derivative obtained by methyl substitution, forming a water-
soluble compound and a thermoresponsive gel. The gelation of this compound can be
performed at physiological temperature by altering salt concentration and composition,
allowing it to be injected into brain lesions by a minimal invasive surgery. Moreover, its
potential use for brain regeneration comes motivated by the approbation of a methylcellulose
system (Methocel A®) in nerve repair by the FDA. Methylcellulose gels injected in rat brain
have demonstrated reduction of cavity area and glial scar thickness and a similar inflammation
area compared with control groups (lesion without gel injection), concluding that methylcel‐
lulose is an appropriate biocompatible biomaterial for brain regeneration [197]. However, the
principal limitation of methylcellulose gels is that they are not biodegradable; for this reason
they have been mixed with biodegradable polymers such as HA to obtain semi-biodegradable
gels for their use in the brain [193].
Other ECM compounds, including LN and fibrin, have been employed as permissive sub‐
strates for brain regeneration; they are usually employed as injectable in situ forming gels or
by mixing with other polymers to improve cell attachment. These substrates are able to
immobilize neurotrophic factors such as BDNF yielding a permissive substrate for neurite
growth and a neuroprotective effect by the incorporation of this molecule. The use of these
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systems in ischemic models has resulted in a reduction of the infarct volume and in the
stimulation of neurogenesis in the dentate gyrus of hippocampus of rats [197]. Hybrid systems
employing fibrin gels and MSCs are improved by the incorporation of a growth factor (bFGF),
attaining advances in cell survival by the reduction of the apoptotic activity. These systems
implanted into rat brain provided more significant improvements in morphological and
functional recovery, including reduction of the cavity lesion and neurite and astrocyte
infiltration within the gels [198]. The use of SAPNs in brain regeneration has resulted prom‐
ising due to the ability of these peptides to form nanofibres percolating in a continuous network
under physiological conditions. The peptide solution can be injected with a non-invasive
surgery and the self-assembled peptides form nanofibrous gels by the presence of ions, filling
entirely the cavity lesion and yielding a natural substrate with molecular and topographical
cues for axon ingrowth. The gelled SAPNs are integrated within the host tissue and reduce the
secondary injury that causes further cell loss, decreasing the lesion volume. Moreover, the
astrocyte activation is lower, which reduces the thickness of the glial scar, and the microglia
activation decreases during the acute inflammation, suggesting that SAPNs can be successful
employed in brain regeneration [199].
6.2. Synthetic biomaterials
Unlike natural polymers, synthetic ones show lower costs, may be tailored in multiple fashions
with different properties, are easier to be obtained and the batch processes are more repetitive
than natural ones. The fabrication methodologies and modifications of synthetic polymers
allow obtaining a wide range of properties and structures for the purposes of brain regenera‐
tion. Thus, substrates with properties similar to those of neural tissue can be produced, either
biodegradable or bioestable in the shape of structures mimicking the natural ECM.
Acrylate-based biomaterials have been widely proposed for peripheral nerve repair. Poly (2-
hydroxyethyl methacrylate) (PHEMA) and poly (hydroxypropyl methacrylate) (PHPMA) are
the most common acrylate substrates employed in brain regeneration, for its ability to form
hydrogels, yielding substrates with similar properties to the natural tissue. Both polymers
show a good biocompatibility and integration with the host tissue adhering firmly to the
surrounding brain tissue [200]. The implantation of crosslinked PHEMA and PHPMA
materials owning interconnected porous structures led to a dense glial scar and CSPGs
deposition surrounding the interface material-host tissue. However, both polymers allowed
the infiltration of astrocytes, tissue compounds (fibroblasts, collagen and blood vessels) and
neurites within the porous structure. PHPMA scaffolds showed improvements towards brain
regeneration in terms of neurite infiltration and presence of larger amounts of neurites and
connective tissue within their pores. However, these scaffolds presented a low cell adhesion,
which can be enhanced by the incorporation of adhesive peptides. Thus, the immobilization
of IKVAV and RGD peptides on PHPMA led to the structural continuity across the cavity,
resulting in a more adequate substrate for axonal ingrowth and reduction of glial scar
[201,202]. PHPMA has been combined with RGD motifs and engineered fibroblasts to express
CNTF and/or BDNF, resulting in larger amounts of regrowing axons, less astrocyte prolifera‐
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tion and similar inflammatory response than hydrogels containing only engineered fibroblasts
[202].
Aliphatic polyesters are a family of synthetic polymers widely employed for CNS regener‐
ation; they are easily obtained by ring opening polymerization. The most common aliphatic
polyesters  are  PCL,  PLLA,  PGA  and  PLLA-PGA  co-polymers  (PLGA).  The  FDA  has
approved the use of these polymers for several tissue engineering purposes, which makes
them attractive in the regeneration of brain damages. A large variety of structures can be
achieved with these polymers due to their easy processing (porous scaffolds, electrospun
fibres,  etc.).  They  show  different  mechanical  properties  and  biodegradation  rates,  the
development  of  a  wide  range  of  intermediate  ones  by  the  possibility  of  forming  co-
polymers.  PCL and PLGA have been designed as porous scaffolds with a spongy struc‐
ture for TBI models and have demonstrated a good biocompatibility with rat brain tissue
[203]. Both polymers have shown the ability to maintain the volume of the lesion cavity
rather  than  control  groups,  preserving  the  healthy  tissue  of  the  primary  injury  and
attenuating the  secondary tissue  loss.  PCL and PLGA reduce cell  death,  induce neurite
ingrowth and do not cause severe inflammation. However, PCL has some advantages over
PLGA  scaffolds  because  it  provokes  a  lower  microglia  and  astrocyte  activation,  and
promotes higher levels of neurite ingrowth [203]. PCL with different architectures has been
tested for brain regeneration. As an example, PCL nanofibres, both random and aligned,
implanted  in  rat  brain  have  shown  a  good  biocompatibility  through  the  absence  of
encapsulation and foreign body response, and they have revealed unexpected results. The
random nanofibrous scaffolds allow neurite infiltration in the fibrous mesh, whereas the
aligned ones show no neurite ingrowth and they are preferentially localized on the surface
of the mesh after 7 days [185].  This phenomenon reveals that aligned fibres constitute a
good substrate  for  neurite  alignment  and growth on its  surface  by  the  phenomenon of
perpendicular contact guidance without infiltration into the inner network. PCL channel-
based architectures with different internal structure (single channel, parallel channels and
perpendicular channels)  have been employed to address brain damages and guide axon
growth in  rats.  All  channel-based structures  have  demonstrated to  be  useful  for  neural
ingrowth and they reduce glial scar formation. Particularly, orthogonal channels resulted
in  the  optimal  structures  for  neurite  alignment  constituting a  more  permissive  environ‐
ment  for  cell  ingrowth  and  tissue  integration,  while  parallel  channels  favour  the  re‐
growth of neurites along the surface of the channel [186].
The most common materials employed for brain regeneration purposes are the mentioned
polyacrylates and aliphatic polyesters, but other families of synthetic polyesters have also been
tested, such as poly (trimethylene carbonate) (PTMC). PTMC can be obtained with different
biodegradabilities, the PTMC with fast degradation and slow resorption showing a similar
degree of brain regeneration than PLGA. Oppositely, PTMC with a fast rate of degradation
and resorption presents a faster and more efficient tissue recovery than common PLGA [204].
Silicon substrates are components also employed in neural interfaces such as electrodes and
their functionalization with the protein of neuron adhesion, L1, has shown reduction in
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astrocyte reaction, fibroblast adhesion, and microglia and macrophages reaction. Moreover,
L1-functionalized silicon increases neurons density at the implant-tissue interface [205].
CNTs have also a great interest in neural tissue engineering due to their electrical properties,
and their problems of biocompatibility can be elicited by chemical modifications. Indeed, both
hydrophobic and hydrophilic modified CNTs have been implanted in the damaged brain of
rats resulting in functional recovery. Their benefits in brain regeneration can be enhanced by
combining NPCs and CNTs; these systems reduce the gliogenesis of NPCs promoting the
differentiation into functional neurons, which restor electrical activity and lead to synaptic
formation [206].
7. Biomaterials for spinal cord regeneration
SCI is usually caused by traumatic injuries, including traffic accidents, acts of violence, falls
and sports injuries. Damages in spinal cord are due to a mechanical insult following a fractured
vertebra or disk intruding into the spinal canal, and can lead to a partial or complete spinal
cord transection. The majority of patients die for respiratory complications, because the injury
at any level of the spinal cord implies difficulties in respiratory function due to the destruction
of the descending motor tracts, which regulate muscles, such as diaphragmatic, thoracic, and
abdominal, implied in the breathing process. Consequently, the patients with SCI require
assisted breathing, and the clinical treatments are limited to reduce the pain and prevent
secondary injuries, including the administration of anti-inflammatory drugs. However, the
classical clinical treatments do not achieve tissue regeneration nor recovery of the lost
functions.
In early stages, the damaged tissue presents necrosis due to physical trauma, hemorrhage and
disruption of the BSCB leading to ischemic processes. The disruption of the BSCB produces
the infiltration of foreign components, including fibroblasts, macrophages and cytokines,
which are involved in the activation of astrocytes leading to the formation of the gliotic scar
and inflammatory processes. After a few days, the apoptotic pathways are activated by the
presence of a toxic microenvironment, producing glial and neurons loss without the possibility
of replacement by the absence of sufficient endogenous progenitors. The primary axonal loss
is followed by a continuous axonal degeneration due to demyelination by oligodendrocytes
loss, the block of signalling and the lack of a permissive microenvironment for axon regrowth.
Moreover, the axon degeneration progresses over months and years, even it can affect the
distal ends of several axons (Wallerian degeneration) leading to the loss of entire spinal tracts.
The axons in the spinal cord form longitudinal bundles, tracts, and they are similar to the nerve
fascicles that compose the peripheral nerves. Thus, several researchers have proposed the use
of nerve conduits for this pathology due to their success for peripheral nerve repair. However,
the spinal cord presents some physiological differences and the regeneration is more complex
due to the limitation of regeneration in the CNS. Owing to the complex geometries, partial
transection founded at spinal cord lesions and the need of invasive surgeries for the implan‐
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tation of guidance conduits, many researchers have considered more convenient the use of
injectable hydrogels.
As stated, the regeneration of the spinal cord requires guidance structures for a correct axon
regrowth, since the tracts in the spinal cord are formed by aligned bundles of axons. Particu‐
larly, tracts in the spinal cord own diameters about 100-1000 μm, so the implanted scaffolds
in the spinal cord must be permissive to the formation of axon bundles around these diameters.
Moreover, the myelinated axons in the spinal cord environment show diameters around 20
μm, thus the SCI scaffolds should be able to guide individual neurite outgrowth as well. The
degree of swelling of a material under physiological conditions is important to maintain an
appropriate alignment and avoid the compression of the regenerating tracts. Other properties,
similarly to what happens with brain regeneration, are important to design scaffolds for spinal
cord regeneration; they include biocompatibility, controlled biodegradability, high surface/
volume to permit cell attachment and the correct nutrient transport, similar mechanical
properties to the host tissue, etc. Guidance structures can be fabricated by different techniques;
the most common ones include rolled sheets of aligned electrospinning, scaffolds obtained by
freeze-drying of polymeric solutions or moulding combined with particle leaching to generate
porosity, or printing the polymers previously designed by CAD software.
7.1. Natural biomaterials
The natural polymers employed in spinal cord regeneration are similar to the ones proposed
for brain regeneration, and include fibrillar proteins, polysaccharides, glycosaminoglycans
and carbohydrates. The most common are the ECM components collagen and hyaluronic acid,
polymers derived from algae such as agarose and alginate, and proteins derived from blood
plasma such as fibrin and fibronectin. They are potential materials for the purpose of spinal
cord regeneration for their possibility of forming hydrogels in situ, avoiding invasive surgeries.
However, they are commonly fabricated as porous scaffolds and guidance conduits to be
implanted in the spinal cord lesions and to permit axon regeneration in an aligned manner.
Collagen has been successfully employed in peripheral nerve guidance channels, resulting in
conduits approved by the FDA as Neuromatrix™ and Neuroflex™. Collagen shows mechan‐
ical properties similar to spinal cord tissue, and possesses peptide-motifs for cell adhesion,
migration, proliferation, etc. It has a good biocompatibility and integration with the host tissue
of the spinal cord, and can be obtained in different shapes, including the aforementioned
guidance conduits [207,208]. However, this material lacks ability to support and promote axon
growth, and consequently its injection to obtain a gel in situ has resulted in dense inclusions
within the gel and cavities at the interface biomaterial/host tissue which impede axon growth
[207]. In most cases, axon attachment and guidance can be promoted by topographical cues.
For this reason, aligned and random collagen electrospun fibres have been developed forming
conduits for SCI models, which have shown good results concerning the integration with the
spinal cord tissue: reduction of the acute inflammatory response, non-formation of glial scar
at the interface between the lesion site and the scaffold, cellular infiltration into the scaffold
and axonal sprouting [208]. However, this system has resulted in low axonal sprouting and
the aligned conduit does not promote neurite alignment. That is, collagen alone does not
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promote axon regeneration or alignment, which is a fundamental task in spinal cord repair,
and its use requires functionalization to incorporate molecular cues, or to combine it with other
permissive substrates of axon guidance and growth. Indeed, collagen has been employed as
filling of other polymers’ conduits, resulting in the absence of axonal ingrowth and regrowth,
but when collagen includes growth factors (FGF or NT3), the axons grow into the channels
[209]. The immobilization of peptides such as laminin improves axonal regeneration in the
SCI; thus, laminin gradients in a collagen gel filling have shown to increase axonal length and
provide directional guidance to the collagen fibres [210].
HA, like collagen, shows a good compatibility with spinal cord tissue but does not promote
axon attachment and growth, impeding regeneration. However, the implantation of HA gels
in spinal cord lesions is able to reduce the lesion cavity, reduces inflammation and gliotic scar
in the surrounded tissue. The reduction of inflammation and gliosis is due to the own nature
of HA: the negative charge of the HA chain inhibits cell attachment and their binding site
interactions with the cell membrane receptor CD44 of macrophages, limiting the inflammatory
effects [211]. HA can be functionalized or combined with other polymers to improve axon
attachment and regeneration. For example, the incorporation of poly-l-lysine into HA gels can
promote neurite attachment, while the incorporation of the nogo66 receptor antibody, which
has an agonist interaction with the inhibitory molecule nogo66, promotes axon regrowth. This
system has yielded to the reduction of the glial scar at injury sites promoting wound healing
and has facilitated angiogenesis; it has even shown improvements in axon regeneration,
leading to both myelinated and unmyelinated axons [212]. The combination of HA with
methylcellulose (HAMC) produces gels in situ, which are employed in brain damages and SCI,
too. This gel has the advantage of covering entirely the lesion cavity, and the possibility of
incorporating factors or other neuroprotective compounds enhancing SCI regeneration. For
instance, the incorporation of EGF and EPO in the HAMC gels has improved neuroprotection
at the implant site and increased neuron density [213,214].
Agarose hydrogels, like collagen and hyaluronic acid, is not adequate for axon infiltration, but
is a good substrate when it is functionalized with protein gradients, of laminin for example.
Axons grow, preferably, up the laminin gradient in vitro, which means promotion of axon
extension and guidance [215]. Agarose permits to obtain conduits with an internal structure
of aligned linear pores, by means of a freeze-drying process with cooling gradients [216]. These
materials show a good biocompatibility and integration within the host tissue, because they
do not cause fibrous encapsulation, nor foreign response, the scaffold-host tissue interface is
continuous and the cystic cavity is rarely observed. The immobilization of BDNF into the
channels promotes blood vessels formation and alignment along the longitudinal orientation
of the channels and enhances axonal infiltration into agarose scaffolds [115]. Agarose can also
be employed as an in situ forming gel, because it is a thermoresponsive hydrogel at tempera‐
tures over 17ºC, but gelation upon cooling is a drawback of injectable hydrogels. However,
Kaoka et al. employed a customized device for quickly cooling; they implanted agarose gelling
in situ with steroids, for SCI models, resulting in a reduction of macrophage infiltration and
lesion cavity [217].
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Alginate is another polymer derived from algae employed for spinal cord tissue engineering.
This material has the ability of forming gels by the interaction of multivalent ions, especially
Ca+2 ions. It has been employed to obtain conduits for spinal cord repair by an ionic diffusion
method, where Ca+2 ions in an alginate solution diffuse by capillarity forming parallel and
aligned conduits with adjustable pore diameters [218]. Alginate gelation in situ under phys‐
iological conditions can be performed by Ca+2 ions forming hydrogels, thus this material can
be employed to form gels in the spinal cord cavities. These gels permit axonal support and
extension and inhibit the gliotic scar formation in the injured spinal cord [219]. The use of
alginate for spinal cord tissue engineering instead of agarose is due to its biodegradability.
Fibrin and fibronectin are two glycoproteins derived from plasma: fibrin is a fibrillary acidic
protein glycoprotein polymer and fibronectin is a plasma glycoprotein dimer. Fibronectin gels
can be obtained with linearly aligned fibres, which orient axonal growth in spinal cord
implants [220] and are more permissive for axon ingrowth than collagen or fibrinogen [210].
However, fibronectin gels implanted alone in the spinal cord generate cavities due to their
slow gelation ability. Fibrin has been employed to fill synthetic conduits, made of poly(2-
hydroxyethyl methacrylate-co-methyl methacrylate) P(HEMA-MMA) for example, resulting
in a greater axonal regeneration specially from vestibular neurons, even obtaining improve‐
ments in locomotor function after complete spinal cord transaction at T8 in rats [209]. Fibrin
can be modified with heparin to incorporate neurotrophic factors, such as NT-3 [221]. The
incorporation of NT-3 into the fibrin matrix reduces the activation of astrocytes inhibiting the
glial scar formation. The reduction of the inhibitory components for axon regeneration can
also be performed by incorporating the enzyme chondroitinase ABC (ChABC), which cleaves
the CSPGs chains generating a more permissive environment for axon regeneration [222].
Fibrin gels are an adequate vehicle to encapsulate embryonic stem cells; its implantation along
with pluripotent cells and growth factors, including NT-3 and PDGF in subacute rat model of
SCI has been found to increase the survival of transplanted cells and resulted in more differ‐
entiated neurons [223]. However, the use of fibrin gels for these applications is falling into
decline for its fast degradation. Because of this drawback, fibrinogen has been combined with
fibronectin to obtain more durable and efficient gels [207]. The fibronectin/fibrinogen gels have
demonstrated a good integration with the host tissue, axonal ingrowth associated with SCs
infiltration and deposition of laminin, abundant vascularization and non-formation of cavities.
That is, fibronectin/fibrinogen gels are more suitable for SCI regeneration than any of them
separately, even than collagen gels.
SAPNs are an interesting strategy to address SCI, due to their ability to be injected and form
nanofibrous gels in situ, acting as contact guidance substrates for axon outgrowth without
employing any invasive surgery. As an example, a negatively charged peptide amphiphile
incorporating the neuroactive pentapeptide epitope from laminin, IKVAV, has been injected
after laminectomy of spinal cord of mouse at the T10 vertebral segment, resulting in a reduction
of astrogliosis and oligodendrocyte apoptosis. Moreover, functional recovery was assessed by
the Basso, Beattie and Bresnahan (BBB) locomotor scale modified for mouse at 9 weeks after
SAPN injection [224]. However, the stability of many SAPNs is poor and need structural
modifications. In this sense, the RAD16-I (Puramatrix™) ionic peptide (multiple of the RADA
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amino acid sequence) has been modified with bone marrow homing motifs to enhance its
stability and bioactivity in the injured spinal cord environment after its gelation [225]. The
injection of this modified RAD16-I has shown to promote the upregulation of trophic factors
and ECM remodelling proteins, an increment in cellular infiltration, together with laminin and
collagen, axon regeneration after 7 days and some improvements in the motor and coordina‐
tion function 8 weeks after implantation. RAD16-I has been implanted in the transected dorsal
column of spinal cord of rats, carrying SCs and embryonic NPCs to replace dead cells and
promote neuroprotection [226]. The implanted cells have survived after 6 weeks, SCs mature
with a tubular morphology and NPCs differentiate into neurons, astrocytes and oligodendro‐
cytes. This system has shown a good integration with the host tissue without gaps between
the implants and the injured tissue at 6 weeks. In addition, host cells have been found to migrate
into the gel and extensive blood vessels have been formed.
7.2. Synthetic biomaterials
The synthetic polymers permit to obtain a wide range of structural designs for spinal cord
repair, including conduits to form bridges between the rostral and caudal ends of the injured
spinal cord, and their properties are more controllable than those of natural polymers. The
synthetic polymers most employed for spinal cord tissue engineering are either biodegradable
materials, mainly the aliphatic polyesters (PLA, PGA, PLGA, PCL), or bioestable ones, such
as acrylate-based hydrogels (PHEMA and PHPMA).
PLA is a good choice for spinal cord regeneration because the FDA has approved its use for
several clinical applications, including absorbable sutures and fabrication of peripheral nerve
grafts. PLA scaffolds have been designed as conduits for axon guidance in the environment
of the spinal cord by a freeze-drying technique, which allows obtaining aligned pores to guide
axon growth. However, the implantation of these conduits with entrapped BDNF in the
transected adult rat thoracic spinal cord does not improve axon regeneration [227]. Further
studies have incorporated engineered SCs expressing BDNF and NT-3 into porous PLA
scaffolds, resulting in modest axon regeneration after 6 weeks, but only a few implanted cells
survived after one week [228]. Regeneration employing PLA can be improved incorporating
topographical cues for axon growth and guidance. For example, PLA conduits have been
developed by rolling random and aligned PLA electrospun fibres [229]. These conduits,
implanted into a 3 mm gap created after complete transaction of thoracic rat spinal cord,
increased cell proliferation and allowed host cells and tissue infiltrate into the lumen of the
conduit, filling the scaffold 4 weeks after implantation, closing the gap and forming a contin‐
uous tissue. Moreover, the PLA fibres promote the regeneration of supraspinal and proprio‐
spinal neurons and glial cells, and aligned fibres promote longer bridge regeneration without
adding other cues for axon regeneration, pointing out the importance of topographical cues
for axon growth and guidance. However, the electrospun PLA conduits are structurally
unstable, easily fragmenting and collapsing.
Lactic acid is normally copolymerized with another aliphatic polyester, glycolic acid (GA), to
obtain the copolymer PLGA, which enhances the properties of implantable conduits and
allows a better control over the degradation rate. Such as PLA, PLGA can be employed to
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fabricate conduits for spinal cord regeneration. Thus, aligned porous conduits of PLGA with
interconnected walls have been obtained by a gas foaming/particulate leaching process for
spinal cord regeneration of rats [230]. These conduits allow the infiltration and longitudinally
alignment of different cells including fibroblasts, macrophages, glia, endothelial cells and
neurofilaments, which grow up to 2.5 mm from the proximal end of the injured spinal cord.
Macrophages are activated in the acute inflammation step but their activity decreases over
time, while astrocytes are localized around the structure and the CSPGs levels surrounding
the bridge decrease. These conduits can be fabricated with different porous structures, either
with small pores (less than 38 μm) or larger ones (63-108 μm), showing differences in the
distribution of cell ingrowth; small pores lead to a less uniform cell ingrowth but an increment
of endothelial cell infiltration and formation of vessel-like structures. However, conduits of
both sizes provided some functional recovery in rats after 14 days, indicating the implant
stability and the plastic organization.
The PLGA copolymer has been employed in combination with neurotrophic factors to promote
neuroprotection and enhance regeneration in mice models of SCI [231]. As an example, PLGA
was shaped as microspheres containing sonic hedgehog (Shh), which is a multifactorial growth
factor related to the spinal cord development, and then it was injected in spinal cord lesions.
This system reduces the glial scar at the injury site, not affecting the inflammatory response,
and provokes an increment in the number of proliferative cells, including NPCs, which provide
a permissive environment for regeneration. These benefits result in improvements in the
locomotor function recovery, that is, some kind of regeneration. PLGA conduits have also been
loaded with neurotrophins such as NT-3 and BDNF [232]. These PLGA conduits were
fabricated by a gas foaming/particulate leaching method, injecting a mixture of PLGA
microspheres and salt particles into an aluminium mould with oriented wires and subjecting
the mixture under pression to obtain a continuous and porous PLGA multichannel. Then the
microchannels were filled with hydroxyapatite complexed with a lentivirus encoding lucifer‐
ase. Once implanted into a rat model of hemisectioned spinal cord, these conduits allowed
fibroblasts and macrophages infiltration, but astrocytes were only observed in the surrounding
tissue. The axon density per channel is increased by releasing neurotrophins in the rostral
position, suggesting the beneficial effect of NT-3 and BDNF in neuroprotection and regener‐
ation. Moreover, the myelinization was enhanced in the channels with lentivirus encoding
both neurotrophins. The neuroprotective effect can also be achieved by incorporating cells
secreting neurotrophic and growth factors into the PLGA conduits. The incorporation of SCs
into PLGA multichannel conduits has demonstrated robust axonal regeneration, but not
functional improvements though [233]. The effect of different channels diameters in these
structures has been studied [234], and those with diameters of 450 μm and 660 μm demon‐
strated axon regeneration after 3 months post-implantation in the transected rat spinal cord,
but the longest axon fibres were found in the smallest channels. Other cells have been seeded
in PLGA conduits and implanted in rat model of transected spinal cord, including NSCs [235].
In this work, PLGA conduits fabricated by a moulding-solvent evaporation process seeded
with SCs or NSCs were implanted after an SCI, resulting in similar axonal regeneration in both
seeded conduits, but relatively poorer than in the control healthy group, and none functional
recovery. However, the system with NSCs seeded in the conduits led to an interesting result,
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since NSCs preferentially differentiated into neurons with some cells with astrocyte pheno‐
type.
PCL has also been proposed for spinal cord regeneration, due to its good mechanical properties
and its slower degradation rate compared with the other aliphatic polyesters. Porous PCL
conduits have been fabricated by a salt-leaching and an injection-moulding process, obtaining
different morphologies for spinal cord regeneration purposes, including cylinders, tubes,
multichannels, open-path architectures with a central core and open-path architectures
without such central core [236]. The different morphologies influence the regenerative process
of the spinal cord and provide different results relative to cell infiltration and tissue response.
In the cylindrical, tubular and multichannel architectures, cell growth has been found to occur
along the outside of the implants, the interior walls being filled with cellular debris, macro‐
phages, and fibroblast-like cells after 1 month. However, the result most discourageous of these
three structures was the secondary cell death within and around the implants after 3 months.
Besides, both open-path structures produced growth of tissue into and along the entire length
of the conduits and less cysts and fibrotic tissue around the implants and the stumps. In
addition, the open-path structures promoted astrocyte infiltration and sufficient contact
guidance to allow the extension of axons across the entire defect length, even many fibres
accomplished to be myelinated.
PCL can be chemically modified to obtain a biodegradable crosslinkable polymer by the
addition of fumaryl chloride and PCL diol under ultraviolet light. This crosslinkable polymer,
poly(ε-caprolactone fumarate) (PCLF), has been employed to fabricate multichannel conduits
for spinal cord regeneration [237]. The benefits in spinal cord injuries of PCLF conduits have
been compared with those of PLGA ones, resulting in a major number of axons in the first
ones. PCL in combination with PLGA has been employed to obtain electrospun fibres conduits
containing a filling of the RAD16-I gel to promote axon attachment and regeneration, and
growth factors and neurotrophic factors (BDNF, CNTF, chABC and VEGF) to be used in a
chronic SCI rat model [238]. The incorporation of RAD16-I into the lumen of the conduits led
to a reduction of cavities, the gliotic scar occasionally appeared surrounding the implants but
less frequently inside the lumen, promoted tissue infiltration, neurite regeneration and blood
vessel formation and alignment. The incorporation of cytokines enhanced neuron maturation
and the formation of axon bundles in all the microchannels, and the regeneration even
continued after 6 months, measured by electrophysiological activity and locomotor improve‐
ments.
Poly-β-hydroxybutyrate (PHB) is a polymer produced by a wide variety of bacteria, it degrades
slowly at physiological temperatures and the metabolites are secreted in urine. In contrast to
aliphatic polyesters, the slow degradation rate and continuous elimination of the PHB avoid
the formation of acidic debris, which can cause inflammation. PHB has been employed to
fabricate conduits composed of two perpendicular layers containing parallel fibres for spinal
cord regeneration [239]. These conduits have been coated with alginate, seeded with SCs and
implanted into the gap generated after cervical SCI in rats, resulting in a reduction of the spinal
cord cavity and the retrograde degeneration of the injured spinal tract. Further studies with
PHB fibres conduits coated with alginate and seeded with SCs resulted in improvements in
Cells and Biomaterials in Regenerative Medicine234
cell attachment, proliferation and survival of SCs and promotion of axonal regeneration within
the conduit [240]. However, only the descending raphaespinal and sensorial neurons grew
within and along the conduit, but not the rubrospinal ones.
PHEMA-and PHMA-based hydrogels are bioestable materials and due to their swelling rate,
they show similar properties to those of the spinal cord tissue. The regenerative ability of both
types of hydrogels has been compared in studies of adult and developing rat spinal cords [241].
Both hydrogels showed a good integration with the host tissue, presenting a minimal glial scar
and cystic formation and the infiltration of connective tissue. They promoted the infiltration
of blood vessels and axons into the pores, but axons grew into the central part of the hydrogels
after eight weeks. Moreover, SCs infiltrated into the hydrogels and along the axons, suggesting
the possibility of obtaining myelinated axons. These hydrogels can be modified with peptides
and neurotrophic factors to improve axon regeneration and generate neuroprotection. Thus,
the incorporation of the cell adhesive site of fibronectin RGD (NeuroGel™) into PHMA
hydrogels with a porous structure obtained by freeze-drying has been found to promote axon
regeneration in injured spinal cord [241]. These systems provoked an early inflammation a few
days following implantation, which decreased gradually. One week after implantation, the
proliferation of capillary sprouts was observed, along with a glial scar surrounding the implant
and a few number of fibroblasts, fibrocytes and macrophages. Over the next weeks, the
implants showed ingrowth of capillaries, infiltration of connective tissue, glial processes and
axons. Moreover, the implants presented neither cystic formation nor secondary axon
degeneration, and the axonal pathways were altered into the rostral stump, showing signs of
morphological changes and regeneration indicating growth cone formation. Similar studies
on PHPMA hydrogels with immobilized RGD and neurotrophic factors (BDNF and CNTF)
resulted in a major number of axons growing into the hydrogels compared with unmodified
ones [202].
Conduits of PHEMA-co-methyl methacrylate with different internal matrices –fillings-
(collagen, fibrin, matrigel and methylcellulose) and growth factors (FGF and NT-3) have been
compared with multichannel conduits and have demonstrated improvements in the regener‐
ation of selective tracts after complete spinal cord transection at T8 in rats [209]. This study
shows that all the internal matrices increase axon density within the channels except the
collagen matrix without growth factors and the multichannel conduits without fillings. The
regeneration of sensory axons was not influenced by the internal matrix and axon growth
factors even hinder it. The different matrices and growth factors affect selectively to different
tracts: fibrin promotes the greatest axonal regeneration of reticular neurons, whereas methyl‐
cellulose does of vestibular and red nucleus neurons, FGF increases the axonal regeneration
of vestibular neurons, and NT-3 decreases the total amount of axons regenerating from
brainstem neurons. Besides, fibrin filling and multichannels accomplish improvements in the
locomotor function. With the aim of improving axon regeneration in the injured spinal cord,
HPMA-and HEMA-based hydrogels have been combined with MSCs so as to deliver neuro‐
trophic factors. In a preliminary study, the survival of MSCs within HPMA and PHEMA
implants has been compared, being it higher in the HPMA hydrogels [242]. Besides, this work
also demonstrated that most of the cells locate in the pores but a few cells migrate to the border
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zones of the spinal cord, pointing out that the use of these hydrogels can be helpful as carriers
of stem cells and their delivery in the lesion site of the spinal cord.
8. Biomaterials in neurodegenerative diseases affecting the striatum
Neurodegenerative disorders are characterized by a progressive loss of neuronal subtypes,
and many of these diseases ultimately lead to a loss of the patient autonomy and even death.
In this chapter, two neurodegenerative disorders that affect the striatum in the brain are dealt
with PD and HD. Both show similar pathology, with many differences, affecting localized
zones of the striatum in the earlier stages and causing the loss of neural subtypes: dopaminergic
neurons in PD and GABAergic ones in HD. The experimental therapies are based on cell
therapy and drug delivery, and the role of biomaterials is to incorporate cells or drugs to
immobilize them into the site of interest.
PD is a neurodegenerative disease affecting around 1% of the population older than 60 years.
It is caused by several factors, but researchers have identified six gene mutations associated
with this incidence, including α-synuclein, parkin, UCH-LI, PINK1, DJ-1, and LRRK2/
dardarin. This pathology is characterized by the loss of dopaminergic neurons in the substantia
nigra of the nigrostriatal tract. For this reason, the striatum reduces dopamine levels and
neuronal projections. Other aspect of PD is the generation of abnormal intraneuronal aggre‐
gates of protein, especially α-synuclein, called Lewy bodies. Further stages of this disease
involve degeneration in the cerebral cortex and autonomic nervous system. The manifestations
of PD include tremor, bradykinesia, rigidity, cognitive decline and finally death. The animal
model commonly employed to study the PD is obtained by administration of 6-hydroxidop‐
amine, which causes the lesion of dopaminergic pathways. In the initial stages of disease, L-
DOPA administration is the most potent therapy to improve motor functions. However, this
treatment becomes less effective in further stages, making necessary to find new therapies.
HD is a dominantly inherited neurodegenerative disease that results from the polyglutamine
expansion in the gene encoding the huntingtin protein. This disease is characterized by the
loss of brain striatal GABAergic neurons, and the degenerative process progressively extends
to other brain regions including cortex. The pathogenesis of HD and the function of the
huntingtin protein are not well understood, but this pathology is characterized by the loss of
medium spiny neurons in the striatum and loss of neurons in the cortex leading to movement
disorders (chorea), dementia, and eventually death. The early stages of HD show a localized
damage in the striatum, which leads this disease to be a potential target for tissue engineering
employing biomaterials. The animal models of HD are obtained by exposing neurons from
striatum to drugs or poisons and by using transgenic animal models overexpressing poly‐
glutamine expansions.
Biomaterials for drug delivery are promising since they can be easily modified to adjust the
release kinetics to the target organ, tissues or cells, they can selectively cross biological
membranes including the impermeable BBB, and the release can be controlled by modulating
the biodegradable properties of the biomaterial carriers. The most common structures
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employed for drug delivery in these neurodegenerative diseases are nanoparticles, liposomes
and hydrogels. The principal problem of the oral administration of L-DOPA is that its pro‐
longed use entails tolerance, and its efficacy is limited by the permeability of the BBB. The
implantation of dopamine-loaded biomaterials into the striatum would be a more efficient
method of controlled release to address PD. The incorporation of dopamine in hydrogels has
demonstrated good results, employing non-cytotoxic biomaterials such as dextran crosslinked
with gelatine for models of PD [243]. The delivery of dopamine can be accomplished during
weeks and produces motor functional recovery in models of hemiparkinsonian rats. However,
the release of dopamine occurs during short times and the behavioural bias reappears. GDNF
is another molecule employed in PD studies, since it has a trophic effect in the dopaminergic
system increasing the production of dopamine, stimulating the regeneration of dopaminergic
neurites [244]. Therefore, the incorporation of GDNF in PLGA microparticles and their
posterior implantation into the striatum of parkinsonian rats has demonstrated improvements
in motor function and increments of fiber density in the striatum [245]. The delivery of GDNF
in the striatum in PD models has also been achieved by transfected fibroblasts expressing this
trophic factor immobilized into alginate-poly-L-lysine microparticles [246]; this implantable
device has shown to increase cell survival and release GDNF during around six months in
parkinsonized rats, resulting in improvements of behaviour.
The immobilization of cells within biomaterials is usually carried out by encapsulating cells
into polymeric microparticles or by attaching them on the biomaterials’ surfaces. The use of
biomaterials pursues to increase cell survival of transplanted cells, control cell fate, maintain
cell phenotype and promote cell engraftment into the interest site. The deficit of dopamine and
dopaminergic neurons loss typical of PD disease could be improved by the incorporation of
cells expressing this neurotransmitter or by stromal cells with the ability to differentiate into
dopaminergic neurons. In both cases, cell survival would be improved by combining cells with
biomaterials. For example, collagen-coated dextran microparticles (Cytodex 3®) together with
chromaffin cells have been implanted into the striatum of rats with 6-hydroxydopamine-
induced injuries of the substantia nigra [247]. The implantable biohybrids did not cause any
inflammation response, increased cell survival and produced functional benefits after 8
months. Similar results have been obtained by incorporating foetal ventral mesencephalon
(FVM) cells into the same Cytodex3® microcarriers. Another system to incorporate chromaffin
cells into the striatum of PD animal models has been developed by employing glass bead
microparticles, which has led to similar results, even long-term functional recovery after
implantation in hemiparkinsonian rats [248]. Alginate is another natural polymer employed
to encapsulate cells for the treatment of neurodegenerative diseases affecting the striatum. Its
microparticles have been combined with choroid plexus cells, which secrete several neurotro‐
phic factors, to study their effect in HD rat models [249]. This device had a neuroprotective
effect by the neurotrophic factor release, a reduction of the lesion cavity and improvements in
the motor function. Synthetic polymers have also been employed in the treatment of neuro‐
degenerative diseases affecting the striatum. As an example, NT-3 immobilized into PLGA
microparticles with LN in their surface have been employed to attach and expand MSCs, and
implanted in hemiparkinsonian rats [250]. LN improves the attachment of MSCs to the surface,
while the neurotrophic factor NT-3 promotes the differentiation of MSCs into neurons. This
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device led to improvements of neuron differentiation and the regeneration of the nigrostriatal
pathway, and subsequently to modest improvements in the behaviour.
9. Concluding remarks
There is a high interest in the use of biomaterials to repair damage in the brain in many of the
most prevalent and burden causing neurologic diseases. Biomaterials can provide a better
environment for the homing and survival of neurons, glia and brain blood vessels, act as
guidance cues for promoting axonal growth, and provide a proper stimulus for the formation
of new synapses and to promote neural plasticity.
Although there is still no clinical application of this research, the wealth of data obtained may
foresee a successful solution in the near future, which still will have to go through all the
regulatory and clinical essays process.
If we are able to provide a way to regenerate and reconstruct the damaged brain, we will turn
the available concept of clinical neurosciences, from procedures that are directed to protect the
damaged brain from further injuries into truly reconstructive neurosciences.
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